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Introduction
Among the different treatments in radiation oncology, hadron therapy is an inno-
vative therapeutic procedure for localized solid tumors, which are difficult to treat
with standard radiation therapy.
Charged ions have good ballistic properties, which give to hadrons a great spatial
precision and reduces the imparted dose to the healthy tissues surrounding the tu-
mor. Moreover, a higher relative biological effectiveness (RBE) and a lower oxygen
enhancement ratio (OER) increase hadron capability to control radioresistant and
anoxic tumors.
At the present some cancer treatment centers benefit of this technique to cure a
great variety of tumor types, ranging from uveal melanomas to chordomas located
at the base of skull or in the spinal region [1], significantly reducing the incidence of
radiation-induced second cancers. Nowadays forty-nine hadrotherapy facilities are
located all over the world, twelve of which in Europe, and provide treatments with
proton and carbon ions.
The main open issue in hadrontherapy is the lack of an accurate knowledge of the
RBE values at different depths in the irradiated tumor. Constant values of RBE
are rather adequate to describe sparsely ionizing radiations, such as fast protons,
although experimental data show a significant RBE increase at the distal edge of
the treated area. Such an assumption is not valid for heavier ions, such as 12C ions,
since their RBE values strongly vary with the depth in tissue.
A physical approach capable to assess the hadron RBE values consists in collecting
the microdosimetric spectrum of the radiation under study at any point of interest.
Microdosimetry is the investigation of the distributions of the energy deposited by
a radiation field in tissue volumes of size close to chromosome dimensions. In the
microdosimetric approach, the local energy deposition pattern and its stochastic
characteristics become important, and mean quantities of radiobiological interest
can be derived.
At the present many laboratories around the world are focusing in the field of mi-
crodosimetry, in particular an European project called BioQuart includes many sub-
projects aimed to study the correlation between the biological effects of radiation
and its energy deposition pattern at micrometric and nanometric scales, including
physical and biological measurements (www.ptb.de/emrp/bioquart-home.html).
Microdosimetric measurements are performed via instruments called mini-TEPCs
(Tissue Equivalent Proportional Counters), which simulate the response of micro-
metric tissue sites to a given irradiation field. In particular this thesis deals with
simulated sizes of the order of 1µm, because this is the order of magnitude of the
chromosome thickness.
At the moment there are few microdosimetric measurements performed in 12C ther-
apeutic beams. The aim of this work is to investigate the performances of mini-
E. Motisi - Development of Microdosimetric Techniques Applied to Hadron Therapy 1
TEPCs in a clinical carbon beam. With this beam, complications due to non-linear
phenomena in the electronic avalanche of the mini-TEPC could occur. In fact, the
high concentration of spatial charge built with high event rates, can disturb the
electric field in the counter and distort microdosimetric spectra. The use of high
gains could in principle speed-up the charge collection process, but can also lead to
distortions in the final spectra.
For this reasons, the mini-TEPC response has been investigated at different volt-
ages, corresponding to different gas-gains, both in low-LET (photons) and high-LET
(fast neutrons and carbon ions) irradiation fields.
This thesis is formed by two sections. The first section is a descriptive part. It is
organized as follows.
• Chapter 1 covers the general features of hadron therapy and the problems con-
nected to the RBE determinations, describing the main models used nowadays
to assess 12C RBEs.
• Chapter 2 focuses on the topic of microdosimetry, defining microdosimetric
quantities and their distributions. The main microdosimetric models to assess
the RBE value of a radiation field and the success of the microdosimetric
approach in determining proton RBE values are also presented.
• Chapter 3 deals with the mini-TEPCs description, including the physics of the
counter, the electronic avalanche formation and the inherent limits of these
detectors. Moreover it describes the electronic chain and the vacuum sys-
tem. Finally, the simulation principle between tissue and propane-TE or pure
propane is introduced.
The second section represents the experimental part, including measurements and
data analysis, and it is divided as follows.
• Chapter 4 concerns mini-TEPCs data analysis. In order to optimize both
in time and quality the data analysis, a GUI/C++-based software has been
developed. The code algorithms are described in this chapter, and the sources
can be found in appendix.
• Chapter 5 introduces the measurements performed with different mini-TEPCs
in a 137Cs gamma field at different applied voltages.
• Chapter 6 describes the measurements performed with different mini-TEPCs
in fast neutron fields at different applied voltages.
• Chapter 7 describes the measurements performed at the CNAO clinic center
with a therapeutic carbon beam. Experimental data are discussed.
• Chapter 8 presents the conclusions, the summary and future prospectives.
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1. Hadron Therapy
1.1 Characteristics of Charged Particle Therapy
Radiation therapy is the treatment of malignant tumors by means of ionizing ra-
diation. This treatment modality relies on the energy losses of energetic parti-
cles traversing a biological target, through ionizations and excitations of the con-
stituent atoms. Therein the cellular nuclei are the main sensitive structures, since
they include the DNA molecules containing the genetic information. In particular,
radiation-induced ionizations can lead to single or double strand breaks in the DNA
structure. While the former can be repaired using the other strand as a template,
the latter are more difficult to repair and can lead to wrong rejoinings of the broken
ends. These misrepairs can then induce mutations, chromosome aberrations, or cell
death.
The most common form of radiotherapy uses photons, with an estimated yearly rate
of 1 patient every 10 million people [4]. Hadron therapy differs from conventional
therapy in many aspects, such as depth-dose profiles, LET1, OER2 and RBE3 val-
ues. These are key quantities in radiation therapy and are discussed in more detail,
later on.
Dose Profile The absorbed dose is a quantity used to quantify the exposure of
a medium to ionizing radiation. The absorbed dose in a point is defined as the
quotient of d by dm, where d is the mean energy imparted to matter in an in-
finitesimal volume dV → 0 in a material with density ρ, and dm is the mass in dV .
It is expressed in gray, where 1 Gy = 1 J · 1 kg−1 [3].
This point quantity is thus defined in the limit of small domains, assuming an
energy density function continuous and derivable in the geometrical space. The
non-stochastic absorbed dose in tissue is the average of this quantity in the tissue
volume, and it is used in radiation protection.
Qualitatively the dose profile for a beam of therapeutic photons or neutrons travers-
ing biological matter exhibits an initial increase followed by a roughly exponen-
tial decrease. Figure 1.1 shows the comparison between the depth-dose curve of a
1The Linear Energy Transfer of a charged particle in a medium is the quotient of dE on dl, where dl is
the distance traveled by the particle and dE is the mean energy-loss due to collisions with energy transfers
less than some specified value ∆ [2], L∆ = (dE/dl)∆.
2OER, standing for Oxygen Enhancement Ratio, is defined as the ratio of the doses necessary to cause
the same biological effect in hypoxic and oxygenated conditions respectively.
3This quantity is defined as the ratio of the absorbed dose of some reference radiation which produces
a given biological effect, to the absorbed dose of the test radiation that produces an identical effect. For a
given radiation R and a reference radiation X, the RBE is RBER = DX/DR, where normally the reference
radiation is 250kV X-rays.
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photon-beam and the curves due to other types of ionizing radiations while travers-
ing soft tissues (e.g. ligaments, skin, muscles, etc.).
Figure 1.1: Comparison between depth-dose curves for photons, neutrons and protons, as in [4].
Energetic charged ions, on the other hand, deposit little energy in their initial path.
The majority of energy deposition takes place at the end of their path, generating
a peak in the depth-dose profile (Bragg peak). After that, the deposited energy
strongly decreases. These features allow to obtain a better dose conformation, and
a more selective tailoring of the biological area to be treated, by using charged ions
instead of photons, neutrons or electrons. For ions heavier than proton, there is also
the advantage of a reduced lateral diffusion, which gives the projectiles even more
spatial precision.
This “inverse-dose” profile is consequence of the interaction mechanisms of heavy
charged ions in the target material. In the energy range used in therapy, they mainly
interact with the target electrons and slow down continuously (Continuous Slowing
Down Approximation). For higher ion energies the interaction time is short, leading
to small energy transfer, while the opposite happens at lower energies. The energy
loss as a function of the ion and target characteristics is given by the Bethe-Bloch
formula given (in non-relativistic conditions) by
− dE
dx
=
4pie4z2effZN
mev2
ln
(2mev2
< I >
)
, (1.1)
where v and zeff are the velocity and the charge of the primary particle (zeff is
equal to its atomic charge at high velocities), me is the electron mass, N and Z are
the number density and the atomic number of the traversed material and < I > is
the mean ionization energy of the target atom or molecule.
In practical situations, due to the narrowness of the Bragg peak of monoenergetic
ions (typically of the order of one millimeter or less), it is necessary to superimpose
several different Bragg-peaks to spread them properly over the tumor area. This is
done by decreasing the energy of the initial ion beam and opportunely weighting the
components of different energy (assigning the relative fraction of dose to be imparted
with a given energy). The result is a "flat-topped" depth-dose curve, known as SOBP
(Spread Out Bragg Peak), depicted qualitatively in Figure 1.2 for a beam of protons.
The advantage of this technique is to decrease the imparted dose in the region before
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and after the tumor site.
Figure 1.2: Depth-dose distributions for a spread-out Bragg peak (SOBP, solid curve) and its constituent
Bragg peaks (dotted curves). The SOBP profile is created by adding several Bragg peaks with different
energy, their number depending on the depth of the region to be treated.
With ions heavier than protons, the depth-dose profile is worsen by the presence of a
tail component of fast charged particle arising from the nuclear fragmentation of the
projectile, which causes a significant amount of energy to be imparted in the distal
part after the tumor. A comparison between the depth-dose curves and SOBPs of
protons and carbon ions is shown in Figure 1.3 and Figure 1.4 respectively.
The radiobiological and clinical effects are directly related to the absorbed dose, yet
this is not sufficient to give an estimate of the complete biological effect, which also
depends on the type of irradiation.
Difference in LET As previously stated, the Linear Energy Transfer L∆ for charged
particles of a given type and energy stopping in a material is the quotient of dE∆
by dl, where dE∆ is the mean energy lost by the charged particles due to electronic
interactions in traversing a distance dl, minus the energy carried away by energetic
secondary electrons produced with kinetic energies greater than ∆. If no energy cut
off is imposed, the unrestricted LET equals the linear electronic stopping power. L∆
specifies the amount of local energy imparted to the target, thus it is linked to the
proximity and distribution of ionization points.
From now on the term LET will refer to the unrestricted linear energy transfer L∞.
Low-LET radiations are for example photons and electrons, where the electrons re-
sponsible for the ionizations are subjected to scattering and deflection at large angles
in the absorber, giving a “sparse” ionization pattern.
For charged ions, the ionizations are mostly included in the core and in the neigh-
boring part of the δ-ray penumbra of the primary track. For this reason charged ion
radiation is also called densely ionizing and leads to higher LET values.
It has been observed that a high-LET radiation is in general more effective in causing
biological damages than a low-LET one, in fact the single or double strand breaks
of the DNA are more concentrated. Carbons have a higher LET if compared to
protons due to their higher nuclear charge. For this reason, a carbon irradiation
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Figure 1.3: Relative depth-dose distributions for a 145 MeV proton beam and a 276 MeV/amu carbon
beam, with a range of ∼14 cm [5].
causes more severe local damages and has a greater effectiveness when treating ra-
dioresistant tumors compared to protons and photons.
Difference in OER The effects caused in an irradiated tumor also depend on the
oxygen content of the irradiated tissues. The amount of oxygen enhances the sen-
sitivity of the irradiated cells, increasing the biological effect of radiation through
the production of free radicals which cause additional damages, other than those
attainable considering only the direct interactions of photons with tissue [19].
The ratio of the doses needed to produce the same effect in the presence and absence
of oxygen is the Oxygen Enhancement Ratio parameter, OER = D/D0, where D is
the dose in the real tissue and D0 is the dose that would be required under complete
tissue oxygenation.
In tumors, the oxygen content may vary, the fraction of hypoxic cells also reaching
100% for some solid tumors. This would require the increase of the dose delivered
for a better tumor control, at the expense of the growth of side effects.
The difference in radiation sensitivity between hypoxic and oxygenated cells has
been proved to decrease if a high-LET radiation is employed, allowing to monitor
the biological response of a tumor independently on its vascularization degree.
1.2 The Problem of RBE Determination
One of the main challenges in hadron therapy is the identification of physical param-
eters related to the biological effects of radiation, such as the inactivation of tumor
cells and the sparing of normal tissues.
Nowadays the Linear Quadratic model (LQ) is used as a model of cell killing. In-
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Figure 1.4: Comparison of calculated SOBPs of protons and carbon ions at a penetration depth of 100
mm (upper figure), 150 mm (middle figure) and 180 mm (lower figure) [6]. The corresponding proton
energies are 116 MeV, 146 MeV and 162 MeV, respectively. The carbon ion energies are 216 MeV/amu,
275 MeV/amu and 307 MeV/amu, respectively.
vitro as well as in-vivo experiments show that the fraction of surviving cells can be
described through a linear-quadratic function of the absorbed dose, namely [8]
S = exp[−(αD + βD2)], (1.2)
where the coefficient α is the slope at small doses and β is the curvature at larger
doses.
This trend of experimental data can be interpreted as follows. When a cell sample
undergoes a given irradiation, the radiation field is responsible for the production
of double-strand breaks (DSBs) or base damage in the DNA, at a rate which is, in
first approximation, proportional to the dose. When pairs of adjacent DSBs wrongly
rejoin together, chromosome aberrations can occur producing lethal lesions.
Experimentally it is found that densely ionizing radiation has a greater biological
impact than X-rays for the same dose level. In fact, X-ray dose response has a
large shoulder at low doses and an exponential decrease at higher doses, as shown
in Figure 1.5, while for charged ions the quadratic component decreases with incre-
asing ionization density (LET) and the survival curve is characterized by a purely
exponential trend.
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Figure 1.5: Definition of the Relative Biological Effectiveness, illustrated for cell survival curves, as in [6].
For different radiations the same level of physical dose can correspond to different
cell survival levels. To cope with the inadequacy of the sole dose concept, and to
compare the biological effects of various types of irradiations, the concept of RBE
has been introduced, defined as the ratio of a reference X-ray dose (typically 250kV
X-rays) to the particle dose to achieve the same biological effect, e.g.
RBE10% =
DX
D
, (1.3)
where the subscript stresses the RBE dependence on the survival level representing
the equivalence point. This definition is depicted qualitatively in Figure 1.5. The
RBE alone does not fully characterize the therapeutic beam, since it depends on the
type and energy of the radiation, on the dose fractionation history, on the biological
end-point and cell-line considered. Because of the non-linearity of the X-ray curve,
the RBE strongly depends on the effect level. For for carbon ions RBE values of
3 or 4 are found at the end of their range, where the high local ionization density
cause clustered lesions producing irreparable DNA damage. For RBE values greater
than one an effective dose Deff is defined
Deff [GyE] = RBE ·D[Gy], (1.4)
measured in Gray equivalent (GyE). In radiation therapy the optimization of the
weighting factors of the various Bragg peaks forming the SOBP must then be made
by taking into account the effective dose, rather than the physical dose, to achieve
homogeneous killing effect over the treated area.
RBE values are not easily accessible, due to the variety of parameters they depend
on, therefore various models have been proposed to estimate RBE values from phys-
ical measurements.
The first radiobiological experiments by Zirkle et al. in 1935 showed that to fully
describe the biological effectiveness of a ionizing radiation, the spatial distribution
of energy deposition must be taken into account.
It was thus proposed to describe the biological damage in terms of the LET of
the incident primary particle, linking the concentration of deposited energy to the
damages in microscopic structures near the particle track. In this view low-LET
radiations are less damaging than high-LET ones.
In first approximation the RBE is related to the LET. The first RBE-LET relation
obtained by Barendesen [9] for alphas and deuterons showed an increase of RBE
with LET until a maximum, then a decrease attributed to cell overkilling. In a
recent work by Sørensen et al. [10], several literature data of the RBE dependence
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on LET have been summarized, showing a correlation between the dose-averaged
LET and the RBE values for three different cell lines (for V79, CHO and T1), as it
can be seen in Figure 1.6.
Figure 1.6: Relationship between RBE and LET for various charged particles irradiating V79 cells, where
the biological endpoint considered is a 10% survival fraction, as in [10].
In general however, the RBE is not a unique function of the LET, the difference being
attributed to the change in the track structure of the primary particles. Moreover,
the LET changes with the traveled depth in tissue and so does the RBE, making
any RBE-value assumption inaccurate.
Currently in proton clinics a RBE value of 1.1 is adopted, despite the evidence of
RBE variations with the depth traveled in tissue (due to proton energy and LET
variations) or dose fractionation, tissue type and biological endpoint. The magni-
tude of these RBE variations is small in the plateau region of the SOBP if compared
to the current abilities to determine RBE values [31], and differences are of the order
of 10÷20% [17], while in the distal edge the differences are much higher.
For heavier ions like carbons, RBE values are higher and their variations with depth
are more pronounced even in the plateau region. In particular, it was shown for
many cell lines that in the initial part of the carbon path the ionizations produce
mostly repairable damages, while the RBE becomes greater than 1 in the last 40 mm
of the carbon track (in water or in biological tissue) [4]. Therefore, the correct in-
clusion of a variable-RBE model in carbon therapy is crucial.
Two of the current approaches to obtain RBE values in carbon therapy are discussed.
NIRS approach At the National Institute of Radiological Sciences, located in
Chiba (Japan), the clinical dose to be assigned to a carbon beam is determined
through an experimental approach, using the clinical experience with fast neutron
beams and a dose-scaling procedure, taking into account just the LET dependency
of RBE [11].
The empirical procedure relies on the observation that the RBE values of a 290MeV/amu
carbon ion beam and of the fast NIRS neutrons are equal when the LET of the car-
bon beam is 80 keV/µm, inducing the same biological effect on a Human Salivary
Gland cell-line (HSG) at 10% survival probability, since these cells are assumed to
be a good marker of the tumor response. This is shown in Figure 1.7.
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Figure 1.7: RBE-LET in-vitro data for the irradiation of HSG and HeLa cells for carbon ion beams with
different energies, as in [13]. The horizontal arrow shows the RBE of NIRS neutrons, the vertical line
marks the LET value of the carbon ion beam which leads to the same RBE value.
The carbon ion dose-depth profile is shaped in order to achieve a uniform in-vitro
SOBP, corresponding to a 10% survival of the HSG cells. Since the neutron-
equivalent point for a 290 MeV/amu carbon ion beam corresponds to a depth
traveled in water of about 150 mm, the constraint is that the RBE at this depth is
equal to 2.
The RBE of fast neutrons used in clinical practice at NIRS is equal to 3. It is
assumed that the in-vitro carbon SOBP can be converted into a clinical SOBP by
simply scaling the in-vitro SOBP for a factor 3/2 at the point of neutron equivalence,
namely the ratio of clinical and in-vitro neutron RBEs. The dose scaling procedure
is illustrated in Figure 1.8.
The main critic to the NIRS approach derives from the fact that the RBE equiv-
alence between neutron and carbons is set independently from the dose and the
radiosensitivity of the irradiated tissues. In principle these parameters should be
taken into account when estimating RBE values.
GSI approach In order to describe the RBE of high-LET therapeutic beams, var-
ious track structure–based models were developed, such as the Local Effect Model
(LEM) developed at GSI [14]. This model is currently used in order to optimize
the treatment planning at the HIT (Heidelberg) and CNAO (Pavia) ion-therapy
facilities.
The idea behind the LEM model is that the critical structures leading to the biolog-
ical damage, are contained in the cell nucleus, which is considered as the sensitive
target. This can be divided into smaller sub-volumes, with nanometric size, where
the probability to induce a damage depends only on the local energy deposition, re-
gardless of the radiation type causing it. In this view, equal local doses correspond
to equal local radiation effects and the biological response to carbon ions can be
derived from X-ray cell survival curves.
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Figure 1.8: Scheme illustrating the determination of the clinical SOBP, as in [13]. The physical dose (solid
line) is converted into an in-vitro SOBP (dashed line) by using RBE values at a 10% survival level for HSG
cells. The in-vitro SOBP is then scaled by a factor 3/2 to obtain the final clinical SOBP (dotted line).
Three parameters are needed as input in the model, to calculate the probability
of cell inactivation for a heavy ion field. The first is the radial dose profile of the
incident primary particle, which is assumed to be constant in the core of the pri-
mary track, and decreasing with the square of the distance in the penumbra. This
allows to calculate the local dose in the sensitive sub-volumes by superimposing the
contributions of the different particles which contribute to the energy deposition in
that volume. The second input parameter is the target geometry, which is assumed
to be a cylinder with experimentally determined radius and which height is kept
small compared to LET variations in that volume. The last parameter are photon
survival curves (fitted by the linear-quadratic model), which are used to make the
connection between the local imparted doses and the actual biological effect.
The principle behind the model is depicted in Figure 1.9.
The model allows to obtain a clinical proton RBE of 1.2÷1.3, and the RBE mapping
for carbon ions.
The main critics to this model arise from the principal assumption. In fact, the
possibility to use a low-LET survival curve to characterize the effect of high-LET
radiations is in contrast with the experimental observation that different-LET radi-
ations produce different effects, due to the different ability of their individual tracks
to produce clustered damages [15].
1.3 Hadrotherapic Centers
The features of charged particles make them useful in the case of spatially defined
solid-tumors. However, particle therapy has also some practical disadvantages. One
issue are the high costs involved, in fact the global investments needed for a proton
therapy and a combined (protons and carbons) facilities are 3.6 and 5.3 times that
of a photon facility, respectively [7]. These arise from the need of a more skilled
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Figure 1.9: The cell nucleus (blue circle) is hit by particles with a given radial dose profile (red circles).
In each cellular sub-volume (black dots) it is possible to calculate the locally imparted dose, knowing the
radial dose profile of the primary particles (shown in the upper left). The local dose deposited is linked to
the cell survival probability through the survival curves obtained for photon irradiation (upper right).
staff and the requirement of dedicated facilities to deliver ion beams.
From the operating point of view, ion therapy is also more sensitive to the depth
traveled in tissue than photon therapy, and the accurate positioning of the patience
together with accurate scanning and imaging techniques is more crucial.
Finally, the determination of the clinical dose to be provided still represents an open
issue. This is discussed in Section 1.2.
Nowadays the existing ion-therapy facilities use protons and carbon ions, which
energy and type is chosen according to the depth of the tumor. A list of the current
treatment centers can be found in Table 1.1. The use of other types of ions is
currently under investigation.
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COUNTRY WHO, WHERE PARTICLE START OF TOTAL PATIENTS DATE OF
TREATMENT TREATED TOTAL
Canada TRIUMF, Vancouver p 1995 175 Dec-13
Czech Republic PTC Czech r.s.o., Prague p 2012 140 Dec-13
China WPTC, Wanjie, Zi-Bo p 2004 1078 Dec-13
China IMP-CAS, Lanzhou C-ion 2006 213 Dec-13
China Fudan University CC, Shanghai C-ion 2014 36 Sep-14
England Clatterbridge p 1989 2446 Dec-13
France CAL, Nice p 1991 4936 Dec-13
France CPO, Orsay p 1991 6432 Dec-13
Germany HZB, Berlin p 1998 2312 Dec-13
Germany RPTC, Munich p 2009 1811 Dec-13
Germany HIT, Heidelberg p 2009, 2012 503 Dec-13
Germany HIT, Heidelberg C-ion 2009, 2012 1368 Dec-13
Germany WPE, Essen p 2013 32 Dec-13
Italy INFN-LNS, Catania p 2002 350 Dec-13
Italy CNAO, Pavia p 2011 76 Dec-13
Italy CNAO, Pavia C-ion 2012 105 Dec-13
Italy APSS, Trento p 2014 first patient Oct-14
Japan HIMAC, Chiba C-ion 1994 8073 Dec-13
Japan NCC, Kashiwa p 1998 1226 Mar-13
Japan HIBMC, Hyogo p 2001 4223 Dec-13
Japan HIBMC,Hyogo C-ion 2002 1935 Dec-13
Japan PMRC 2, Tsukuba p 2001 2967 Dec-13
Japan Shizuoka Cancer Center p 2003 1590 Dec-13
Japan STPTC, Koriyama-City p 2008 2306 Dec-13
Japan GHMC, Gunma C-ion 2010 985 Dec-13
Japan MPTRC, Ibusuki p 2011 919 Dec-13
Japan Fukui Prefectural Hospital PTC, p 2011 428 Dec-13
Fukui City
Japan Nagoya PTC, Nagoya City, Aichi p 2013 199 Dec-13
Japan SAGA-HIMAT, Tosu C-ion 2013 62 Dec-13
Japan Aizawa Hospital PTC, Nagano p 2014 first patient Oct-14
Poland IFJ PAN, Krakow p 2011 39 Dec-13
Russia ITEP, Moscow p 1969 4320 Dec-13
Russia St.Petersburg p 1975 1386 Dec-12
Russia JINR 2, Dubna p 1999 995 Dec-13
South Africa NRF - iThemba Labs p 1993 521 Dec-13
South Korea NCC, IIsan p 2007 1158 Dec-13
Sweden Svedberg Lab.,Uppsala p 1989 1356 Dec-13
Switzerland CPT, PSI, Villigen p 1984, 1996, 2013 7045 Dec-13
USA, CA. J. Slater PTC, Loma Linda p 1990 17829 Dec-13
USA, CA. UCSF, San Francisco p 1994 1621 Dec-13
USA, MA. MGH Francis H. Burr PTC, p 2001 7345 Dec-13
Boston
USA, IN. IU Health PTC, Bloomington p 2004 1927 Dec-13
USA, TX. MD Anderson Cancer Center, p 2006 4746 Dec-13
Houston
USA, FL. UFPTI, Jacksonville p 2006 5085 Dec-13
USA, OK. ProCure PTC, Oklahoma City p 2009 1364 Dec-13
USA, PA. Roberts PTC,UPenn, Philadelphia p 2010 1744 Dec-13
USA, IL. CDH Proton Center, Warrenville p 2010 1329 Dec-13
USA, VA. HUPTI, Hampton p 2010 767 Dec-13
USA, NY. ProCure Proton Therapy Center, p 2012 512 Dec-13
New Jersey
USA, WA. SCCA ProCure Proton Therapy p 2013 86 Dec-13
Center, Seattle
USA, MO. S. Lee Kling PTC, Barnes Jewish p 2013 93 Oct-14
Hospital, St. Louis
USA, TN. Provision Center for Proton p 2014 100 Aug-14
Therapy, Knoxville
USA, CA. Scripps Proton Therapy Center, p 2014 first patient Feb-14
San Diego
USA, LA. Willis Knighton Proton Therapy p 2014 first patient Sep-14
Cancer Center, Shreveport
Table 1.1: Hadrontherapy facilities worldwide in operation (source www.ptcog.ch,updated 09-Nov-2014).
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2. Microdosimetry
2.1 Microdosimetric Quantities
As stated in Chapter 1, a correct evaluation of the biological effects due to a given
kind of irradiation field is unfeasible without knowing the details of the energy depo-
sition pattern. The main biological sensitive structures are chromosomes and DNA.
At the chromosome level the stochastic characteristics of the energy deposition are
dominant, due to the interplay between the discrete distribution of the sensitive
components in irradiated matter and the discreteness of the microscopic energy de-
position pattern.
The main objective of microdosimetry is the investigation of the imparted-energy
probability distributions in irradiated matter [40], considering single charged-particle
passages across the volume of interest (single events), of micrometric size.
A basic microdosimetric quantity is the energy deposit i which is the energy ab-
sorbed in a given transfer point, given by
i = Ein − Eout +Q, (2.1)
where Ein is the energy of the ionizing particle without taking into account its rest
mass, Eout is the sum of the energies of all particles leaving the transfer point and
Q is the change in the rest masses, that has to be considered when nuclear reactions
or pair production are involved, since they can further release (Q > 0) or absorb
(Q < 0) the energy. The point of interaction is called transfer point when the
deposited energy exceeds the minimum value required to cause a given change (e.g.
ionization).
The number of the relevant transfer points is linked to the probability of occurrence
of a given biological effect.
The quantity  describes the sum of all the energy deposits in the site arising from
one or more particles and their secondaries. This is a stochastic quantity, since the
underlying physical processes are stochastic.
The lineal energy is the ratio of the energy imparted to the volume due to a single
event  to the mean chord length l¯ of the volume
y = 
l¯
. (2.2)
The mean chord length of a convex volume is the mean length of randomly oriented
chords in the volume which, according to a theorem by Cauchy, for a convex body
with volume V and surface area S is given by the equation
l¯convex =
4V
S
, (2.3)
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which will be recalled in Section 3.2. This parameter is introduced to take into
account the geometry of the interaction, since the paths of energy deposition can
intersect the site through a variety of chord lengths.
The occurrence of the different lineal energy events can be described through the
frequency probability density f(y) and the fraction of dose imparted between events
of different dimensions, is described through a dose distribution d(y).
The relation between the two probability densities is
d(y) = y
y¯F
f(y), (2.4)
where y¯F is the frequency-averaged lineal energy value.
The specific energy imparted z is the ratio of the energy imparted to the volume and
the mass m inside it
z = 
m
. (2.5)
Similarly to the case of lineal energy, the frequency f1(z) and dose d1(z) probability
densities can be defined, where the subscript 1 refers to a single event. In this
condition the lineal and the specific energy are proportional to each other.
For a large number of events in the site volume, the distribution of specific energy
shows small fluctuations from its mean value, and the average value of multi-event
specific energy can be thought as the absorbed dose
D ≈ z¯ =
∫ ∞
0
zf(z)dz, (2.6)
where f(z) is the multi-event distribution that can be derived from f1(z) through a
convolution operation [40].
2.2 Graphical Presentation of a Microdosimetric spectrum
Microdosimeters analyze a variety of radiation fields, from fast electrons produced
by gamma radiation to low-energy heavy recoils produced in neutron fields. Due
to this feature, a microdosimetric spectrum must be capable of inspecting a broad
range of imparted energies, covering several orders of magnitude. A lower limit is
set by the smaller observable event which is the production of one electron, typically
30 eV (approximately the ionization potential of the employed TE gases). The up-
per limit strongly depends on the inspected flux of charged particles and can achieve
hundreds of keV.
To deal with this large range of energies and to compare results obtained under dif-
ferent experimental conditions, the conventional approach consists in dividing the
lineal energy axis into equal logarithmic intervals, while presenting the frequency or
dose distributions on a linear axis.
In the frequency distribution spectrum, equal areas represent equal fractions of ob-
served events, while in the dose distribution spectrum equal areas between different
lineal energy values represent equal fractions of imparted dose by those events.
The details of the logarithmic presentation are discussed later on, in Section ??.
An example of microdosimetric spectrum for a neutron source is presented in Figure
2.1.
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Figure 2.1: Frequency (normalized counts) and dose distributions for a neutron source, as a function of
the lineal energy.
2.3 RBE Determination
As stated in the previous chapter, the RBE of a therapeutic beam is related to
the spatial distribution of energy deposition events, as this influences the biological
effectiveness of a radiation. RBE can be described through physical microdosimetric
measurements, which are more reproducible and faster than radiobiological ones.
Microdosimetric approach Radiobiological and microdosimetric measurements
taken in the same conditions, can be used to assess the RBE of a generic irradi-
ation field by determining an empirical distribution in the lineal energy domain
called biological weighting function r(y). This parameter actually depends on the
radiobiological parameters at which it is calculated, such as biological endpoint and
absorbed dose, and on the simulated biological size in microdosimetric spectra. Its
E. Motisi - Development of Microdosimetric Techniques Applied to Hadron Therapy 17
determination is based on the assumption that the information on single event spec-
tra d(y) is sufficient to determine the contribution of different radiation components
to the total biological effectiveness.
In particular, the microdosimetric RBE values are defined as
RBEµ =
∫ ∞
0
r(y)d(y)dy ≈
ymax∑
y0
r(yi)d(yi)∆yi., (2.7)
The advantage is that the microdosimetric measurements can be performed for a
wide variety of irradiations, and the function r(y) can be obtained through iterative
unfolding methods [22].
Few r(y) distributions have been derived in literature using different RBE-d(y) sets.
For example in work by Pihet et al. [23] the r(y) function was obtained from ra-
diobiological RBE values for early effects in mice at 8 Gy for clinical beams of fast
neutrons, and microdosimetric spectra at 2 µm site size. In a successive work by
Loncol et al. [24] the feasibility of this procedure was studied for beams of fast
protons, leading to the extension of the r(y) function, presented in Figure 2.2.
Figure 2.2: Biological weighting function for early intestine damage in mice at 8 Gy at 2 µm simulated
size, as in [24]. The red bars represent r(y) uncertainties.
As an application of these findings, the physical quality of the therapeutic proton
beam of the Center Antoine-Lacassagne of Nice has been measured in a measure-
ment campaign by De Nardo et al. [25] and RBEµ have been calculated using the
different weighting functions present in literature for early intestine damage in mice
at 8 Gy. It was then made a comparison with in-vitro radiobiological data of human
melanoma and human tongue cell carcinoma surviving at 2 Gy. The comparison
showed that the radiobiological RBE values are well fitted by the calculated RBEµ
values within their uncertainties, including the statistical errors on the d(y) distri-
butions and the r(y) uncertainty, when the function of Figure 2.2 is used.
In Figure 2.3 it is shown the comparison of radiobiological and microdosimetric
RBEs, as a function of the depth in ocular tissue (the pristine Bragg peak cor-
responds to a proton energy of 61.5 MeV). Taking into account RBEµ values the
effective dose imparted is calculated, and it is shown in Figure 2.4. The biological
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Figure 2.3: Comparison between radiobiological and microdosimetric RBEs, as in [25]. The full line is
the proton SOBP and the triangles are RBE for human tongue cell carcinoma at 2 Gy, the open circles
RBEs for human melanoma cells at 8 Gy. The full circles are RBEµ values calculated with the weighting
function of Loncol et al. [24] at 8 Gy. RBEµ values calculated with the weighting function of Tilikidis et
al. at 10 Gy and at 2 Gy [26] are represented by the continuous line and dashed line.
effective dose varies of the 30% along the SOBP and presents the highest variation
in the distal part, showing that the radiation damage for protons cannot be con-
sidered uniform inside the irradiated volume. Moreover, the microdosimetric data
show that the effective distal edge of the SOBP shifts of about 0.5 mm, which can
lead to a significant dose contribution in the healthy tissues surrounding the tumor.
From these measurements it was also shown that the microdosimetric approach is
effective in monitoring therapeutic beams, by using suitable weighting functions.
MKM model Throughout the years microdosimetric quantities have often been
used in models describing the occurrence of biological lesions, such as the clustered-
damage model called the Theory of Dual Radiation Action (TDRA). This was pro-
posed by Kellerer and Rossi in 1972 [34], who postulated that the effect of ionizing
radiation on cells is the production of entities called sublesions, with a rate pro-
portional to the specific energy in the target volume. In the model, the sublesions
combine in pairs to produce the lesions responsible of the various biological effects,
which expectation value  will accordingly be proportional to the square of the
specific energy
(z) = Kz2. (2.8)
Even if some of the assumptions of TDRA were invalidated by experimental tests
[35], the Microdosimetric Kinetic Model (MKM) of cell death incorporates aspects
of TDRA and other models as mathematical formalism [36].
In the model the lethal lesions can be due to the combination of two sub-lesions,
but also to the lack of repair of single sub-lesions after a certain amount of time,
thus introducing a term proportional to the imparted energy
(z) = αz + βz2. (2.9)
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Figure 2.4: Physical absorbed dose and biological effective dose (circles and dashed line) comparison, as
in [25].
In the description of the dose-effect relationship, the model takes into account the
dimensions of the domains containing the critical targets and the LET of the ir-
radiating field, together with the repair capability of the system from a kinetic or
“temporal” point of view.
This model has been recently tested experimentally at the NIRS center in Japan,
with the aim to include it in future treatment planning [27], [28].
Other applications
Area monitoring In area monitoring a quantity called quality factor Q gives an
indication of the dose equivalent, which is important in unknown radiation fields.
Area monitors measuring microdosimetric spectra are of practical importance, since
the probability density d(y) can be used to asses the mean quality factor [32] through
the relation
Q =
∫ ∞
0
q(y)d(y)dy, (2.10)
where the functions q(y) substitute the classical dependence of the quality factor on
LET Q(L∞), established in early works of radiation protection [33], typically setting
y = 98L∞ [42].
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3. Detectors and Experimental Setup
Microdosimetric measurements are performed with different types of detectors, the
most common ones being gas-filled TEPCs (Tissue Equivalent Proportional Coun-
ters) and solid-state detectors.
A common property is that the energy imparted by the incident radiation in the de-
tector is converted into a measurable signal, which amplitude is proportional to the
energy imparted. Each different detector has its advantages and limitations when
investigating microdosimetric spectra.
3.1 Tissue Equivalent Proportional Counters
In this thesis the performances of a cylindrical mini-TEPC (Tissue Equivalent Pro-
portional Counters) under different irradiation conditions are investigated. Mini-
TEPCs are miniaturized gas-filled proportional counters, simulating tissue volumes
of micrometric size and density of 1g/cm3 by means of a tissue-equivalent gas at
low pressure. The mini-TEPC under investigation was developed years ago at the
LNL-INFN laboratories specifically for radiation therapy applications.
The gas is enclosed in a cavity surrounded by cathode walls and including a central
anode wire. The energy deposition in the counter sensitive volume (SV) ionize the
atoms of the filling gas, then the produced electrons drift towards the anode and are
then amplified through a phenomenon of gas multiplication. The collected charge is
then converted into a voltage pulse, typically by means of a charge sensitive pream-
plifier.
The pulse amplitude deriving from a given energy deposition event varies according
to the gas amplification factor, determined by the voltage difference between the
cathode and the anode. This must be chosen in order to work in the region of true
proportionality, where the collected charge is proportional to the number of original
ion pairs created by the incident radiation [51].
Simulation principle The mini-TEPC SV has millimetric dimensions and the de-
tector operation relies on a “scaling” procedure based on the equality between the
mean imparted energy in the gas-filled cavity of the TEPC and that in the simulated
tissue site. The mean imparted energy in the two volumes is approximated by the
energy released by charged ions in the CSDA approximation, where the Bethe-Bloch
Equation 1.1 can be used.
Indicating with ∆Xt and ∆Xg the characteristic dimensions of the tissue volume
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and gas cavity respectively, the equality of the imparted energy becomes(
S
ρ
)
t
ρt∆t =
(
S
ρ
)
g
ρg∆g, (3.1)
where (S/ρ)t and (S/ρ)g are the mass stopping powers in tissue and gas respectively
and ρt and ρg their densities.
The equation can be further simplified if the tissue and the gas have an identical
atomic composition, so that (S/ρ)t = (S/ρ)g, assuming that mass stopping powers
are density-independent. With these constraints, the simulation of a given tissue
size ∆Xt just requires to properly choose the gas density, according to
ρt∆Xt = ρg∆Xg. (3.2)
In operative conditions the parameter to be changed is the gas pressure, which is
given by
Pg =
ρg
Mg
RT, (3.3)
where Mg is the molar mass of the gas or mixture, R ≈ 8.31Jmol−1K−1 is the ideal
gas constant and T is the gas temperature.
Tissue equivalent materials In order to properly apply the simulation principle,
the density variation at the interface between the counter walls and the filling gas
should not affect the energy deposition from the primary particle. According to
Bragg-Gray cavity theory [41] states that the fluence of secondary particles from
a given incident radiation will be constant and independent on density variations
if homogeneity between the counter walls and the gas is achieved. For this reason
the counter walls must be made of tissue-equivalent materials, the most common
being A-150 TE plastic, which composition is very close to the standard muscular
tissue, as seen in Table 3.1. The greater amount of carbon is necessary to ensure its
electrical conductivity properties.
TE-Solid H C N O F Na Mg P S K Ca
ICRU muscle (ICRU, 1964) 10.2 12.3 3.5 72.9 - 0.08 0.02 0.2 0.5 0.3 0.007
A-150 plastic (Smathers et al., 1977) 10.1 77.6 3.5 5.2 1.7 - - - - - 1.8
Table 3.1: Elemental composition of standard ICRU muscle-equivalent tissue and A-150 plastic [42], ex-
pressed as a percentage in weight.
However the density variation can lead to the scattering of the primary particle,
and branches of secondaries and tertiaries will be generated departing from the pri-
mary particle track. This causes a perturbation in the energy deposition, causing
ionizations which in general will not take place in the direction of the original track.
These phenomena are called “wall-effects” and they can distort the experimental
microdosimetric distributions [42]. They are more significant for electrons (more
subject to deflections in the medium), they are also more relevant with increasing
cavity size, and finally depend on the particle “quality” (namely nuclear charge Z,
velocity and mass). An example of wall effect is shown in Figure 3.1, where a curved
track experiments distortions at the interface between two materials with different
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Figure 3.1: Schematic representation of a wall effect, where the curved track in the high density (a) and
low density (b) materials can be distorted at the interface between the two (c), resulting in a distorted
spectrum of released energy within the site [40].
densities.
The gas mixture to be employed is chosen to give the best approximation to the
tissue composition and to provide homogeneity with the walls. Another requirement
is to avoid the presence of electronegative elements, since in this case the electrons
generated in ionizations would not be free to form the electrical avalanche, affecting
the counting characteristics of the gas. The two main filling gases are propane and
methane based tissue-equivalent gases, which are described in Table 3.2.
Gas-mixture H C N O CH4 C3H8 CO2 N2
Methane-TE (Rossi and Failla, 1956) 10.2 45.6 3.5 40.7 64.4 0 32.5 3.1
Propane-TE (Srdoc, 1970) 10.3 56.9 3.5 29.3 0 55 39.6 5.4
Table 3.2: Elemental and molecular composition of standard muscle-equivalent gas mixtures [42], expressed
as a percentage in weight.
Compared to the methane-based mixture, the use of propane-TE presents better
counting characteristics and it is more similar to the A-150, thus it is preferred.
In this work the mini-TEPC has been filled with pure propane. This has a higher
stability over time and has higher gain characteristics compared to the propane-TE
mixture. The drawback is that pure propane is not tissue equivalent. For this rea-
son the material equivalence for the different filling gases of the TEPC is achieved
by investigating the equivalence of the ionization distributions inside the gas cavity,
which are later converted into energy imparted distributions. A paper by Chiriotti
et al. [43] showed that in order to have the same ionization spectra of the TEPCs
filled with TE-propane the density of pure propane must be reduced by a factor of
0.75 as compared with the TE-propane density.
Gas properties The proportionality constant between the number of ionizations
produced by the radiation and the collected charge is determined by a gas charac-
teristic, called gas gain.
It is defined as the mean number of electrons collected at the anode wire per pri-
mary ion pair produced by the ionizing particle [42]. It depends on the geometry of
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the sensitive volume, the voltage difference between the anode and the cathode, the
type of the filling gas and the pressure inside the detector volume.
The general formula for the gas gain is linked with the Townsend first-ionization
coefficient αt, that quantifies the number of ion pairs per unit length generated by
one primary electron, through
n(d) = n0eα·d, (3.4)
where d is the distance traveled by the electron and n0 is the number of primary
electrons.
The relationship between the gas gain and the ionization coefficient is
ln(G) =
∫ rc
ra
αtdr, (3.5)
where rc and ra are the cathode and anode radii respectively, while dr is an elemen-
tal radial distance in the direction of the electric field.
Qualitatively the first ionization coefficient decreases with a decreasing electric field
and with a increasing gas pressure, since the smaller electronic mean-free path pre-
vent electrons to reach the energy to cause secondary ionizations. The αt coefficient
thus depends on the reduced electric field S, that in cylindrical geometry is
S = E
N
= 1
r
∆V
ln(rc/ra)
· 1
N
, (3.6)
where N is the gas number density and ∆V is the voltage difference between the
anode and cathode.
For a uniform electric field the reduced Townsend coefficient αt/N is a function of the
reduced electric field only [44], while for non-uniform electric fields the dependence
on the reduced voltage K = ∆V/ln(rc/ra) must also be included [47].
This description of the gas gain has been studied in a work by Colautti et al. [47],
and is valid for reduced electric field values exceeding S? = 850 · 10−17 V cm−2, such
that reached in mini-TEPCs. In this approach the reduced gas gain is described as
ln(G)
K
=
∫ Sa
Sc
αt
N
(S,K) 1
S
dS, (3.7)
where the reduced Townsend coefficient αt/N is calculated through
αt
N
= L
Vi
exp(−MSm−1), (3.8)
where Vi is the effective ionization potential of the gas, L and m are gas parameters
and M is a function of the reduced voltage
M = LK
Vi
[
exp
(
Vi
K
)
− 1
]
. (3.9)
With this expression of αt the reduced gas-gain becomes
ln(G)
K
= L
MVi(1−m)
[
exp(−MSm−1a )− exp(−MSm−1c )
]
, (3.10)
which is known as the gradient-field model.
The gas parameters are determined through fitting of the gas-gain data and once
known they allow to determine the gas gain as a function of the pressure and the
applied voltage. In Figure 3.2 it is presented the variation of the gas gain for a
mini-TEPC as a function of the distance from the anode wire.
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Figure 3.2: Gas gain calculated with the gradient-field model of Equation 3.10 using a mini-TEPC with
cathode diameter 0.9 mm, anode diameter 10 µm, filled pure propane at 454 mbar pressure, with an
applied voltage difference of 800 V . The gas gain is almost constant up to a distance of about 100µm from
the anode wire, while below this value it is dependent on the position. In this particular case the region
of constant electronic avalanche occupies approximately in the 98.8% of the SV.
Considerations on mini-TEPCs operation During operations it is fundamental
that the multiplication zone is confined near the anode wire, in fact if the avalanche
region is small enough, the gas multiplication does not depend on the point of for-
mation of the primary ion/electron pairs.
The gas gain should be increased to achieve a fixed gain value, for example by de-
creasing the pressure in the cavity. However, lowering the pressure enlarges the
fraction of the detector SV occupied by the avalanche, namely the region where the
gas gain is dependent on the primary ionization position. This effect leads to a loss
in energy resolution of the system. For this reason there is a limit on the pressure
or, equivalently, the site size that can be simulated.
The gas multiplication increases quickly with the applied voltage, thus the propor-
tional counter must be operated with very stable voltage supplies.
A condition that has to be avoided while working with mini-TEPCs is the distortion
of the electric field inside the counter arising from a build-up of space-charge [51].
This effect is most prominent near the anode wire, where most multiplication takes
place. The electrons are quickly collected leaving behind the positive ions, which,
due to their greater masses, move about 1000 times more slowly and can cause an
electric field screening effect. In this situation the avalanches are not independent
and the energy resolution can be affected. In addition this effect arises when in-
specting high-rate radiations. For this reason the gas gain must be kept as low as
possible, also taking into account the signal to noise requirements.
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3.2 Experimental Setup
3.2.1 Mini-TEPCs
The detector used is a cylindrical counter which SV has millimetric dimensions. The
small size allows to obtain a high spatial precision and to reduce the pile-up effects
that arise when high-rate particle beams are inspected, due to the small number of
intercepted particles. In addition, the small diameter allows to house them inside
a 8-French cannula for minimally invasive surgery, opening the possibility of an in
vivo monitoring of the therapeutic radiation fields.
The performances of a new mini-TEPC designed at the Legnaro National Labora-
tories were studied.
The AMiCo 6 detector (Adrotherapy Mini Counter) is housed in a cylindrical alu-
minum shield, with an external diameter of 2.7 mm. Its sensitive volume is ap-
proximately a right cylinder with a diameter of 0.9 mm. Two cylindrical cavities
are placed at the two ends of the SV (diameter of 150 µm and height of 200 µm)
to avoid the potential damage caused by the electronic avalanche to the insulating
material surrounding the anode wire. The anodic wire which traverses the sensitive
volume is made by gold plated tungsten and its stretching is maintained by means
of a spring. Its diameter is 10 µm. The cathode is made of a A-150 plastic, which
composition is described in Table 3.1. The electrodes isolation is provided by means
of an insulating plastic Rexolite 1422 surrounding the cathode and part of the anode
wire.
The sensitive volume has been designed to avoid the perturbation of the electric
field inside the cavity that can occur when high-LET radiation are inspected, since
the large yield of the positive ions produced can lead to a polarization of the insu-
lating materials surrounding the cavity [49]. The technical design of the detector
is not presented due to patenting reasons. Figure 3.3 shows a scheme of a previous
detector AMiCo 3 which is identical to the AMiCo 6 detector, apart from the shape
of the SV.
Figure 3.3: Scheme of the AMiCo 3 detector, the green part represents the sensitive volume, the red part
is the cathode and the yellow part is the insulating plastic. On the right the pipes for the gas entrance
and exit are indicated.
The size of the sensitive volumes of the detector allows to work with intense beams,
where the presence of pile-up effects could distort the microdosimetric spectra. In
particular, if the minimum time required by the electronics to discriminate a signal
is τ , the probability that two different signals will be discriminated is given by [51]
P = e−ΦAτ , (3.11)
where Φ is the flux of particles and A the section of the detector intercepted by the
flux of particles. This probability thus decreases with increasing detector section,
for a given particle flux. Considering for example a typical flux of therapeutic pro-
tons of 107 cm−2s−1 and a typical shaping time of 250 ns, a commercial spherical
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TEPC by Far West Technology, of 1.27 cm in diameter, corresponds to a probability
P = 4%, while for the mini-TEPC analyzed in this thesis this probability reaches
P = 98%.
The detector is connected to an aluminum box housing the preamplifier, the con-
nections to the gas circuit (described in Section 3.3), the electrical connections for
the high (cathode and anode) and low (preamplifier) voltage supply and a sen-
sor to monitor the internal pressure in the detector SV, which full scale range is
1000 torr ≈ 1333 mbar.
A picture of the detector together with the electrical connections is shown in Figure
3.4.
Figure 3.4: Picture of the AMiCo 6 detector, with the gamma irradiator where radioactive sources can be
placed during measurements. The hole facing the detector has a diameter of about 6 mm.
3.3 Gas System
For a correct TEPC operation, first a high vacuum level has to be provided to clean
the counter (typically 10−5 ÷ 10−7 mbar). This operation must be performed for a
sufficiently long time (e.g. two days) to ensure that a steady vacuum condition has
been achieved.
After that, the gas mixture can be inserted in the detector cavity. It is not possible
to ensure the purity of the gas mixture over time, since gas absorption or degassing
phenomena can take place. For example the walls made of TE plastic can adsorb
water vapor, releasing electronegative gases. The constancy of the gas mixture is
ensured by continuously flowing the gas in the counter, which can be achieved by a
feedback-pumping system. This is fundamental to ensure the reproducibility of the
measurements and of the results.
The system to provide the vacuum and the gas to the detector is sketched in Figure
3.5.
The high level of vacuum required is provided by means of a turbo pumping station,
type HiCube 80 by Pfeiffer Vacuum, which maintains a stationary vacuum level of
approximately 10−5 ÷ 10−7 mbar. During the pump operation all the valves shown
in Figure 3.5 are opened, apart from the gas valve.
After the vacuum stage, the gas valve is opened and the gas circuit is fed at 103 mbar.
The gas flow inside the counter is controlled by an electronic module, called Mass
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Figure 3.5: Pictures and schematic drawing of the vacuum and gas-flowing system. The C3H8 flow is
controlled by the MFC module, placed right before the TEPC input. The manometer placed downstream
of the detector regulates the opening of the yellow valve, which controls the gas exit.
Flow Controller (MFC). The gas pressure in the detector is maintained to the desired
value by means of an an electric valve which regulates the gas exit, which is controlled
by a manometer placed downstream of the detector. The detector steady pressure
value can be set on the front panel of an electronic module, together with the steady
value of the gas flux, which is normally set to 4 cc/min.
3.4 Electronic Chain
The setup used to process the output signals from the detectors is sketched is Figure
3.6.
The detector is coupled to a charge sensitive preamplifier, which output is sent in
parallel to three different shaping amplifiers, carrying out the gaussian filtering of
the signals, depending on the shaping time set in the front panel. These amplifiers
have different gains in order to approximately cover 4 or 5 orders of magnitude of
the input signal. The amplifier outputs are sent to three multichannel analyzers
that digitize the voltage pulses. Their output is sent via a SCSI-bus to a PC, to
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Figure 3.6: Schematic drawing of the electronic chain employed.
acquire the spectra and perform the oﬄine analysis.
Preamplifier The detector is coupled to a charge sensitive preamplifier, which aim
is to produce a pulse proportional to the total collected charge Q arising from an
event. The rise time of the pulse is chosen as a compromise between the electron
and ion collection times in the detector, while the fall time is determined by the time
constant of the circuit, product of the feedback resistor Rf and capacitance Cf . The
output pulse height of the preamplifier is given by Vout = −Q/Cf , so the negative
signal from the electronic avalanche is converted into a positive output signal.
Due to the high dynamic range of the energy deposition events, the ideal preamplifier
should exhibit a linear behavior over 4/5 orders of magnitude and should also have
low noise features. The preamplifier is housed within the mini-TEPC in order to
minimize its input capacitance, hence the noise.
The preamplifier used during measurements has been specifically built taking into
account the low noise requirements for mini-TEPC operation. It has an electronic
noise level of approximately 350µV rms, corresponding to ∼ 260 electrons rms, and
has a linear behavior over almost 105 orders of magnitude corresponding to a range
of imparted energies from about 30eV to 2MeV .
Amplifiers The output signal from the preamplifier is fed to three different ampli-
fiers. Their function is to shape the signals that will be send to the ADCs, performins
a gaussian filtering. The shaping time can be set in the front panel. During the
measurement this has been set to 250ns, in order to work at high counting rates.
The amplifiers have three different gains, in order to cover the full dynamic range
of the preamplifier. The signals are sent in parallel to the amplifiers. The high gain
output is gathered after a delay module, preventing the acquisition to be paralyzed
when a high-energy signal saturates on this amplifier. The medium- and low-gain
amplifier modules have an intrinsic temporal delay of about 3 µs, so an additional
delay module is not necessary.
ADCs The gaussians output of the three amplifier is fed to three ADCs having a
dynamic range of 0 ÷ 10V . The first ADC digitizes low energy signals into 214 =
16384 channels. The other two are 13 bit ADCs (213 = 8192 channels) and accept
the signals from the medium- and high-LET events. These modules register the
number of counts for each energy deposition event.
The spectra recorded exhibit a superposition region, which is necessary to join them
to obtain a single microdosimetric spectrum. The maximum event rate which can
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be analyzed with this acquisition system is about 100 kHz.
Pulse generator In order to calibrate the electronics, converting the ADC channel
number in volts, a precision pulse generator provides a signal simulating the output
pulse from the detector. The signal has a finite rise and decay times, which can be
set in the front panel of the pulser. A calibration of the electronics can be then per-
formed through a series of precise attenuators, obtaining a correspondence between
ADC channels and pulse amplitude. In this way, the linearity of the electronic chain
can be tested.
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4. Data Analysis
The software used for data analysis was written in C++, with a graphical user
interface designed with the Qt framework (qt-project.org).
In the subsequent part the three ADCs with different gains are called low-LET
(LL), medium-LET (ML) and high-LET (HL), with reference to the part of the
microdosimetric spectrum inspected.
Figure 4.1 shows a flow chart illustrating the main algorithms implemented in the
software. Each of the graphs produced can be saved in “.png” format by the user.
A “log” containing the analysis output is also produced, and can be saved by the
used in “.txt” format.
The software has been used in the measurement shifts with the mini-TEPC described
in the following chapters. The short time required for the algorithms execution (few
seconds) allows to speed-up the analysis steps, and to have a prompt visual feedback
on the validity of the measurement procedure (e.g. to exclude errors in the pulse
height calibration or test the constancy of the electronic chain linearity).
For the detailed explanation of the performed operations, the analysis of a 137Cs
gamma and a neutron spectra are presented.
4.1 Pulse-height Calibration and Logarithmic Rebinning
The data file with the registered ADC counts can be selected by the user in the
main window, together with the work directory that will contain the output files of
the analysis. The user can choose the number of ADCs to take into account. Figure
4.2 shows a screenshot of the collected counts due to a neutron source source, where
the detected signals fall in the three ADCs.
The pulse height calibration of the spectra is performed through a linear regression
of the pulse amplitude data as a function of the ADC channels. As a test input a
precision pulser is used, with a series of precise attenuators that can divide the pulse
amplitude by the factors ×2, ×5, ×10, ×20, ×50, ×100, ×200, ×500 and ×1000.
For each ADC the channel x corresponding to a given pulse is related to the pulse
amplitude in mV through the calibration equation
yk[mV ] = ak + bk · xk[channels], (4.1)
where k = {LL,ML,HL}. The linear regression algorithm is presented in Appendix
A.1. An example of calibration is shown in Figure 4.3 for a test input with 840 mV
amplitude.
After the ADC calibration the collected counts in each ADC are rebinned in a log-
arithmic presentation.
The pulse height abscissa is divided in N decades and B logarithmic intervals per
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Figure 4.1: Diagram illustrating the analysis steps implemented in the software. The green rounded boxes
show the user interactions while the red boxes present the seuence of performed operations. The details
on the implemented algorithms are discussed in more detail in the text.
decade, which can be set by the user.
The minimum value of pulse height to consider ymin is also given as input by the
user.
Starting from ymin, the software searches automatically for the maximum mV value
registered by the three ADCs, then calculates the number of decades N , the mini-
mum and maximum exponents on 10 to consider (emin, emax) and the lower limit of
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Figure 4.2: Shot of the software plots of the ADC counts registered for a neutron source.
Figure 4.3: ADCs calibration equations using a reference 840 mV pulse amplitude. The channel number
corresponding to a given pulse-height is set as input by the user.
each decade
y
j={0,...,N−1}
0 = 10emin+j. (4.2)
In the decade j, the k − th value of y is calculated as
yjk = y
j
010
k−jB
B , (4.3)
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where k runs from j ·B to (j + 1) ·B, namely all the points in the decade.
The widths of the intervals in the full spectrum are then calculated through
∆yi = yi ·
(
10B2 − 10−B2
)
, (4.4)
where i = {0, ..., N ·B − 1}.
The counts falling in each ∆yi are then averaged, obtaining the rebinned counts Ni.
The corresponding pulse height is set as the middle point of the ∆yi interval.
The new counts are then presented with their density N(yi)/∆yi, as it can be seen
in Figure 4.4. The code for calibration and logarithmic rebinning is presented in
Appendix A.2.
Figure 4.4: ADC counts rebinned with the logarithmic presentation described in Section 4.1 for a 137Cs
(upper figure) and a neutron source (lower figure). On the left the calibration equations are shown.
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4.2 Superposition Regions and Determination of the Cut Point
The next step consists in joining the ADC spectra. The plots obtained from the pre-
vious analysis step, are used to identify the superposition regions between adjacent
ADCs. Their lower and upper limits can be selected through a marker, as shown in
Figure 4.5.
Figure 4.5: Region of superposition of the low- and medium-LET spectra from a 137Cs source. The marker
positions is automatically detected and stored in the forms on the left side of the figure.
The logarithmic data corresponding to a region of superposition are fitted using
the linear regression algorithm in Appendix A.1. The linearity of the superposition
region is checked by calculating the compatibility coefficient λ of the slopes, e.g. for
the LL and ML superposition
λ = |bLL − bML|√
σ2bLL + σ
2
bML
. (4.5)
The maximum acceptable value of lambda is here set to λ = 2, above this value
the two superposition regions are not considered parallel. The user can repeat the
compatibility check by choosing a new superposition region, or can discard the input
data.
After the compatibility check, the cut point is calculated. For its determination the
relative difference di between the counts Ni of the two data sets in each lineal energy
interval ∆yi is evaluated through
di =
NMLi −NLLi
NLLi
, (4.6)
together with its uncertainty, given by
σ(di) =
1
NMLi
√√√√σ2
NLLi
+
(
NLLi
NMLi
)2
σ2
NMLi
. (4.7)
The weighted mean of the differences d¯ and the sample variance σS are then calcu-
lated, through
d¯ =
N ·B∑
i=1
di
σ2(di)
/N ·B∑
i=1
1
σ2(di)
, (4.8)
and
σS =
N ·B∑
i=1
(di − d¯)2
/
N ·B − 1. (4.9)
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The variance contribution at each lineal energy value is used to determine the cut
point, which is chosen as the central point in the region exhibiting the minimum vari-
ance. Figure 4.6 shows an example of junction between the low- and medium-LET
spectra from a 137Cs source. The code implementing these operations is presented
in Appendix A.3.
Figure 4.6: Linear fit of the low- and medium-LET data in the superposition region, for a 137Cs source
(upper figure) and the relative variance contribution of the differences between data (lower figure). The
region of minimum variance in this particular case shows a minimum at about 4 mV .
4.3 Microdosimetric Spectra and Uncertainties
The cut points allow to join the different spectra and to obtain a single spectrum,
by using a number of user-specified intervals per decade. This is usually set equal
to 60. In fact, when greater values are used the data fluctuations, which can arise
for example from a spectrum acquired with poor statistics, become relevant. On
the other hand, if the number of intervals is too small there is a loss on the lineal
energy resolution of the microdosimetric spectra.
The number of counts N(yi) in each logarithmic interval ∆yi is divided by the width
of the bin, obtaining the normalized density of counts n(yi).
The width of the bins is constant in the logarithmic presentation, in fact
∆(log10y) = log10(yi)− log10(yi−1) = 1
B
. (4.10)
. The logarithmic presentation of the frequency distribution requires
ymax∑
i=y0
f(yi)∆yi =
ln(10)
B
ymax∑
i=y0
yif(yi), (4.11)
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which means that the ordinate is multiplied by the lineal energy size in the semi-
logarithmic representation. In the logarithmic presentation f(yi) is the probability
density of the occurrence of the yi value which has been counted Ni = n(yi)∆i times,
and it is given by
f(yi) =
n(yi)∑ymax
y0 n(yi)∆yi
. (4.12)
The same holds for the dose distribution
ymax∑
i=y0
d(yi)∆yi =
ln(10)
B
ymax∑
i=y0
yid(yi). (4.13)
The weighted probability density of the yi value is calculated as
d(yi) =
yin(yi)∑ymax
y0 yin(yi)∆yi
. (4.14)
Finally, the frequency-averaged and the dose-average lineal energy values are then
calculated through
y¯F =
ymax∑
y0
yif(yi)∆yi, (4.15)
and
y¯D =
ymax∑
y0
yid(yi)∆yi. (4.16)
As for the uncertainties on the calculated data, the standard deviation of the number
of counts Ni in each lineal energy interval ∆yi is derived from the Poisson statistics
σNi =
√
Ni. (4.17)
The statistical uncertainty on the frequency density value in the interval ∆yi is
calculated following the recommendation of Moro et al. [55]
σf(yi) =
√
f(yi)
∆yi ·NTOT , (4.18)
where NTOT is the sum of all events in the spectrum.
The y¯F value is calculated with its statistical uncertainty
σy¯F =
√√√√N ·B∑
i=0
(
yi∆yiσf(yi)
)2
. (4.19)
The statistical uncertainty on the dose density value in the interval ∆yi is calculated
by recalling Equation 2.4
σd(yi) = d(yi)
√√√√(σf(yi)
f(yi)
)2
+
(
σy¯F
y¯F
)2
. (4.20)
Finally, the y¯D value is calculated with its statistical uncertainty
σy¯D =
√√√√N ·B∑
i=0
(
yi∆yiσd(yi)
)2
. (4.21)
An example of such distributions is shown in Figure 4.7. The code implementing
the described algorithms is presented in A.4.
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Figure 4.7: Presentation of the frequency and dose density distributions together (upper and bottom right
panels) with the calculated y¯F and y¯D values, for a 137Cs (upper figure) and a neutron source (lower
figure). The differences in the pulse height distribution are more evident in the dose distribution presented
at the bottom right, where the contribution of higher pulses is evident for the neutron source.
4.4 Fermi Fit and Energy Calibration
The final step consists in the energy calibration of the spectra. If the calibration
parameters are already known they can be inserted directly by the user. Normally
microdosimetric spectra in mini-TEPCs are self-calibrated by using the method of
the proton or electron edge [56].
This method is based on the identification of a significant marker point in the mi-
crodosimetric spectrum to which a well-defined lineal energy value is associated. In
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particular, if the microdosimetric spectrum contains a proton or an alpha compo-
nent (e.g. in a neutron field), this marker point can be found in the so called proton
edge or alpha edge. In this region of the spectrum there is a lineal-energy cutoff due
to the maximum energy deposition of these particles in the gas-filled cavity of the
mini-TEPC. This maximum energy loss Emax can be calculated with the energy-
range tables, e.g. [59], [60] or [61].
If the proton or alpha components are not present, the electron edge of an external
gamma source can be used, although the electron straggling phenomena makes the
edge less sharp. In the case of electrons the stopping power decreases monotoni-
cally with increasing energy, thus the maximum energy is deposited by the electrons
which range exactly matches the diameter of the mini-TEPC sensitive volume (exact
stoppers). The corresponding electron energy Emax can be found in energy-range
tables, e.g. [57] or [58], and the maximum of lineal energy can be found.
In any case, since the mini-TEPCs used are right cylinders with height and diameter
equal to D, the mean chord length is l¯ = 2D/3, thus the maximum of lineal energy
is ymax = Emax/l¯. The problem of the correct assignation of this lineal energy value
to a given marker point in the microdosimetric spectrum has been described in a
work by Conte et al. [56].
The edge region in the yd(y) dose distribution has been experimentally found to be
well fitted by a Fermi-like function [56]
F (yd(y)) = A1 + exp(B(y − C)) , (4.22)
where A is the highest value of the function, C is the position of the inflection point
of the function and B related to the slope of the function in the inflection point.
Three different marker values of lineal energy can be recognized in the edge region
and are presented in Figure 4.8, showing the electron edge region for a 137Cs gamma
source at 1 µm. These are the inflection point itself
yflex = C, (4.23)
the position of the maximum of the second derivative
y∂∂ =
ln(2 +
√
3)
B
+ C (4.24)
and the position of the tangent through the inflection point
yTC =
2
B
+ C. (4.25)
With reference to Figure 4.8, the marker values are presented in Table ?? for
different choices of the fitting intervals.
The value of lineal energy ymax is thus assigned to the yTC parameter, which has
been proved to be the least affected by variations of the statistics (number of points
in the fitting interval) and the various possible fitting intervals.
To perform the fit, the user sets the upper and lower limit of the data set in the edge
region by using two markers. The data are then fitted using the least-squares method
based on the Levenberg-Marquardt algorithm. For the algorithm implementation
the suggestions presented in [62] were adopted. The initial guesses for the parameters
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Figure 4.8: Electron-edge region for a 137Cs source source at 1 µm. The open circles are experimental
data, the thick line is the Fermi function. The corresponding lineal energy markers are highlighted by the
vertical lines, as in [56].
Figure 4.9: A, B and C parameters of the Fermi-like function fitting the experimental electron-edge data
presented in Figure 4.8, as in [56]. The parameters are obtained by varying the fitting intervals, presented
in the left column. The corresponding y∂∂ and yTC values are also calculated.
are directly calculated by the software.
The procedure gives, after a convergence, the three fit parameters A, B and C, and
calculated the corresponding quantities yflex, y∂∂ and yTC .
The result of the electron edge fit for a 137Cs gamma source is shown in Figure 4.10.
The code is presented in Appendix A.5.
For electrons the dependence of the maximum lineal energy deposition at a given
simulated size d in a cylindrical counter filled with TE-propane gas, is described by
the formula [56]
ye−edge
keV/µm
= 15.5
(
d
keV/µm
)−0.42
, (4.26)
where d is expressed in µm.
For protons and heavier charged particles the maximum stopping power must be
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Figure 4.10: Fit with a Fermi-like function of the electron edge region of a 137Cs source. The fitting
interval is set in the left graph, where the experimental data are plotted. The fitting parameters with their
uncertainties and the calculated lineal energy markers are shown at the upper right. In the graph on the
right the fitting Fermi-like function is plotted.
calculated iteratively by employing energy-range tables.
In any case, the user can insert the lineal energy value corresponding to the edge,
obtaining the final microdosimetric spectra calibrated in lineal energy.
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5. Measurements in low-LET fields
These measurements investigate the AMiCo 6 capability to detect low-LET events.
The detector is exposed to a 137Cs source emitting 0.66 MeV γ-rays. The source is
housed in a cylindrical lead shield, as in Figure 5.1. The detector sensitive volume
is then placed as close as possible to the source.
Figure 5.1: Picture of the AMiCo 6 detector placed in the gamma irradiator housing the radioactive source.
Before the measurements a vacuum level of 10−5 mbar has been provided in the
whole gas-flowing system.
The filling gas of the detector is pure propane. The gas pressure is set in order to have
the same number of ionizations occurring in propane-TE massic sites of 0.3 mg/cm2,
0.5 mg/cm2, 1.0 mg/cm2 and 2.0 mg/cm2. In particular, the equivalence in the
ionization yield prescribes the following relation between the massic sites d in pure
and TE-propane [43]
dC3H8−TE [mg/cm2] = dC3H8 [mg/cm2]× 0.75, (5.1)
and the pure propane density must be scaled accordingly.
Table 5.1 shows the C3H8 pressure corresponding to a massic tissue site dt (ρt =
1 g/cm3), the corresponding propane massic site dC3H8 , at a temperature of T =
293 K.
The value of 0.3 µm represents the lowest size measurable with the mini-TEPC, in
fact by lowering the gas pressure the gas gain increases, but at the same time the
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dt [mg/cm2] dC3H8 [mg/cm2] Pg [mbar]
0.3 0.225 136
0.5 0.375 227
1.0 0.75 454
2.0 1.5 908
Table 5.1: Pressure of pure propane and simulated tissue size, calculated with Equation.
multiplication region becomes wider, due to the increase in the mean free ionization
path of the produced electrons. This causes an increasing probability that the pri-
mary ionization events are located outside the drift region, where the multiplication
factor of electrons depends on the distance of the primary ionization point from the
anode. The lack of uniformity in the multiplication phenomenon inside the counter
causes the decrease in the energy resolution of the system. This is shown in Figure
5.2, where the avalanche extension is presented as a function of the simulated size,
when other parameters are kept constant.
Figure 5.2: Gas gain calculated with the gradient-field model, as a function of the distance from the anodic
wire, at different simulated site sizes in pure propane, for a potential difference of 600 V . The avalanche
extension with respect to the counter volume is approximately 0.4% for 2.0 µm, 1.9% for 1.0 µm, 7.7% for
0.5 µm and 19.7% for 0.3 µm.
During operation the detector was secured to a support frame to ensure a steady
position during the measurements. In fact small movements of the central anode
wire can induce microphonic noise at the input of the preamplifier.
At each pressure different voltages were applied between the anode and the cathode.
The lowest potential difference for each size is the minimum required to discriminate
the detector signal from the noise level.
The ADC calibration has been performed by using a tail pulse from the precision
pulser simulating the detector signal, with the characteristics shown in Table 5.2.
Particular attention has been paid to the correct evaluation of the offset in the
calibration equation of the high-gain ADC. This parameter has been proved to be
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Amplitude Rate Rise time Fall time
890 mV 2.5 kHz 200 ns 500 µs
Table 5.2: Settings of the test input signal to calibrate the electronics.
crucial since when it strongly differs from zero it can lead to a strong deformations
in the microdosimetric spectra [54].
The linearity of the electronic chain was tested, and the overlap between the dif-
ferent electronic chains was optimized by properly choosing the amplifier gains. In
order to work with the vary intense therapeutic beams, the shaping time was kept as
low as possible to reduce potential pile up effects. In these test measurements it was
thus set to 250 ns, which is the minimum value settable in the amplifier modules.
The presence of a correct pole-zero cancellation was also checked.
The electronic noise level at the preamplifier output has been monitored by means
of an oscilloscope, model Tektronix TPS 2012B. During the measurements it ranged
in the interval 300÷ 700 µV .
The microdosimetric spectra are calibrated in energy by using the electron-edge
method described in Section 4.4. The values of the electron edge, calculated with
Equation 4.26 are presented in Table 5.3.
dt [mg/cm2] ye−edge [keV/µm]
0.3 26.01
0.5 20.88
1.0 15.5
2.0 11.51
Table 5.3: Lineal energy corresponding to the electron edge at different tissue equivalent massic sites,
calculated with Equation 4.26.
5.1 Low-LET spectra
The detailed electronic chain employed is presented in Figure 5.3.
Figure 5.3: Scheme of the electronic chain showing the details of the electronic modules models.
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An example of pulse-height spectrum is shown in Figure 5.4, where the normal-
ized yd(y) distributions collected at different voltages for a simulated site size of
d = 2.0 µm are shown.
Figure 5.4: Microdosimetric spectra collected for a 137Cs source at different voltages, for a simulated site
size of 2.0 µm in pure propane.
It can be seen from Figure 5.4 that the electron edge shifts to higher values with
increasing voltage, reflecting an increase in the gas gain. The variations of the Fermi
fit intercept with applied voltage are presented in Figure 5.5 for each simulated size.
Different pressures correspond to different spatial extensions of the electronic avalanche,
as in Figure 5.2, so the multiplication phenomenon starts at a lower voltage differ-
ence.
The voltage increase allows to inspect also smaller LET events, causing a steep in-
crease in the counting rate, as shown in Figure 5.6.
The complete set of calibrated spectra is presented in Figures 5.7, 5.8, 5.9 and 5.10.
At each site size it is possible to determine the threshold voltage allowing to resolve
the full gamma spectrum. With low voltages just the events corresponding to the
energy deposition of the exact stoppers are detected, while at higher voltages the
electron “crossers”1 contribution is also resolved.
The microdosimetric spectra retain their shape with varying voltage, except for the
region close to the noise level.
1“Crossers” are particles originated outside the sensitive volume that cross the sensitive volume, de-
positing part of their energy in it.
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Figure 5.5: Variation of the un-calibrated 137Cs electron-edge position with the applied voltage, for different
simulated site sizes in pure propane. The lines represent the exponential curves fitting the experimental
data.
Figure 5.6: Variation of the counting rate for the 137Cs source with the applied voltage, for different
simulated site sizes in pure propane.
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Figure 5.7: Microdosimetric spectra calibrated in lineal energy for a 137Cs source at different voltages, for
a simulated site size of 2.0 µm in pure propane.
Figure 5.8: Microdosimetric spectra calibrated in lineal energy for a 137Cs source at different voltages, for
a simulated site size of 1.0 µm in pure propane.
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Figure 5.9: Microdosimetric spectra calibrated in lineal energy for a 137Cs source at different voltages, for
a simulated site size of 0.5 µm in pure propane.
Figure 5.10: Microdosimetric spectra calibrated in lineal energy for a 137Cs source at different voltages,
for a simulated site size of 0.3 µm in pure propane.
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6. Measurements at the CN accelerator, LNL-INFN
The response of the mini-TEPC AMiCo6 has been investigated in an intense beam
of fast neutrons, produced from the reaction of 5.5 MeV deutons on a 7Li target.
The neutron projectiles are produced with energies up to 20 MeV , together with a
8Be recoil.
Energetic deutons are provided by the CN accelerator at the LNL-INFN facility,
a vertical electrostatic accelerator of the “Van de Graaff” type. The accelerated
deutons are directed towards a LiF target through a series of magnetic deflectors.
The beam current varied in the range 280÷ 310 nA.
The position of the microdosimeter SV with respect to the target is shown in Figure
6.1.
Figure 6.1: Detector position with respect to the lithium target.
Measurements were performed in pure propane by simulating different site sizes of
0.3 µm, 0.5 µm and 2.0 µm. These are intended as tests to find the optimal working
conditions for future microdosimetric measurements in therapeutic beams at these
simulated sizes.
The corresponding propane pressures have been calculated in Section 5.1. At each
simulated size, several voltage differences have been applied in order to analyze
the TEPC response at different gas gains. The complete set of measurements is
presented in Table 6.1.
The electronic chain optimization procedure is the same as that of the previous
sections. The electronic noise level at the preamplifier output was 700 µV rms. The
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Site size [µm] Propane pressure [mbar] Voltage [∆V ]
0.3 136 470, 500, 550, 600, 650, 700
0.5 227 500, 520, 550, 600, 650, 700, 730
1.0 454 600, 650, 700, 710, 720, 730, 740, 750, 770, 800, 820, 850
2.0 908 720, 750, 770, 800, 850, 900, 950, 980
Table 6.1: Set of measurements performed the CN accelerator.
shaping time of the amplifiers was set to 250 ns. During the measurements the
constancy of the ADC calibration has been repeatedly checked.
For the lineal energy calibration of the spectra, parallel measurements with a 137Cs
source were performed.
6.1 Results
When interacting with the tissue equivalent plastic constituting the counter cathode,
fast neutrons mainly collide with the hydrogen nuclei through elastic collisions [53],
leading to the presence of a proton peak in the microdosimetric spectra, responsible
for the majority of the absorbed dose. The proton edge can be distinctly identified
at a lineal energy around 150 keV/µm, while the contribution of α particles resulting
from (n,α) can be identified at higher lineal energies.
For the lineal energy calibration the proton-edge was used. Its values for different
simulated sizes are reported in Table 6.2.
Site size [µm] yp−edge [keV/µm]
0.3 152.0
0.5 150.0
1.0 146.3
2.0 136.8
Table 6.2: Lineal energies corresponding to the proton edge for different simulated site sizes [61].
The collected spectra calibrated in lineal energy are presented in Figures 6.2, 6.3,
6.4 and 6.5 for different simulated sizes.
At each simulated size, some features of the microdosimetric spectra depend on the
applied voltage.
In the case of a simulated size of 0.3 µm, at 470 V to 500 V the proton and alpha
peak are evident, and the only variation in the spectra shape is due to the improve-
ments in the lower energy threshold with the higher gas gain (voltage). The further
voltage increase allows to inspect lower energy deposition events due to the gamma
component of neutron induced reactions. As a drawback, the high-LET part of the
spectra begins to shrink, which is evident at 600 V. This feature is ascribed to a
self-screening effect in the electric field inside the counter when high-LET events are
inspected. This phenomenon marks the saturation point of the electronic avalanche.
In this situation the higher-LET events are detected as lower energy events, with a
strong modification of the spectra shape.
These features are presented at each simulated size.
The set of voltages that can be applied at each size without loosing the information
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Figure 6.2: Microdosimetric spectra calibrated in lineal energy in a neutron field at different voltages, for
a simulated site size of 0.3 µm in pure propane.
on the high-LET events and changing the spectra shape, is presented in Table 6.3,
together with the lowest lineal energy measurable yth. It is to be noted that low-LET
Site size [µm] ∆V [V] yth [keV/µm]
0.3 470÷550 0.67
0.5 500÷600 0.76
1.0 600÷720 0.34
2.0 800÷850 0.47
Table 6.3: Optimal voltage ranges for the mini-TEPC application at different simulated sizes.
events also include the gamma component due to target activation. This is not fixed
during time, and it is difficult to evaluate. As an example, the measurement at a
simulated size of 2.0 µm at 800 V was repeated at two different times in the mea-
surement shift. The result is presented in Figure 6.6, where the gamma component
in the second measurement is increased of a factor of about 1.2.
The analysis of the neutron data is still ongoing, since the measurements were per-
formed in late March 2015. The obtained results will be fundamental for the next
measurement campaign at the LNS-INFN laboratories, where the mini-TEPC will
investigate a fixed beam of carbon ions for eye therapy.
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Figure 6.3: Microdosimetric spectra calibrated in lineal energy in a neutron field at different voltages, for
a simulated site size of 0.5 µm in pure propane.
Figure 6.4: Microdosimetric spectra calibrated in lineal energy in a neutron field at different voltages, for
a simulated site size of 1.0 µm in pure propane.
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Figure 6.5: Microdosimetric spectra calibrated in lineal energy in a neutron field at different voltages, for
a simulated site size of 2.0 µm in pure propane.
Figure 6.6: Microdosimetric spectra for a simulated site size of 2.0 µm in pure propane at 800 V, collected
at different times.
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7. Measurements at CNAO, Pavia
The AMiCo 6 mini-TEPC has been tested using a therapeutic carbon beam at the
CNAO facility in Pavia.
The aim of these measurements is to investigate the TEPC performances when high
fluxes of high-LET particles are inspected. Up to now the majority of microdosi-
metric measurements with carbon ions are not made with clinical beams. The test
of the microdosimeter response in a real therapeutic plan is crucial to study the
feasibility of a microdosimetric assessment of the clinical beam RBE.
7.1 Beam Characteristics
At the CNAO facility the carbon ions are accelerated by a synchrotron of 25 m di-
ameter, and the extracted beam (spill) can be brought to three different treatment
rooms. During the treatment an active beam scanning modality is used. The tumor
to be treated is divided into slices perpendicular to the beam direction, each reached
by particles with the same range. The energy is automatically varied by the syn-
chrotron so as to choose the proper slice to treat. Each slice is then “painted” with
the particle beam, which moves within the slice thanks to two scanning magnets. A
sketch of the active beam system is presented in Figure 7.1.
Figure 7.1: Illustration of the active scanning system.
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The measurements were performed with a monoenergetic carbon ion beam with en-
ergy 195.2 MeV/amu, equivalent to a 80 mm range in water.
Due to its narrowness, the Bragg peak was widened by using two ripple filters (pas-
sive energy modulators) to better investigate the Bragg peak region. The reference
depth-dose curves with and without the double ripple filter for a single pencil beam
are shown in Figure 7.2. The zero position is set at the isocenter of the therapeutic
beam, which is a reference point marked by laser light in the treatment room.
Figure 7.2: Depth-dose curves with and without the double ripple filter for a 195.2 MeV/amu carbon
beam.
The field irradiates a water phantom where the mini-TEPC can be inserted, cover-
ing a square of area 3× 3 cm2, centered at the isocenter. The square is then divided
into 15× 15 voxels. The irradiation is performed by scanning each of the 225 spots
in sequence, repeating this procedure 10 times. The FWHM of the beam changes
from aabount 0.7 mm to 6.2 mm, when using the double ripple filter. A scheme of
the spatial distribution of the irradiated spots is shown in Figure 7.3.
Each measurement (2250 irradiated spots) consists approximately of 90 spills, each
spill covering 25 spots. From the temporal point of view the spills last 1 s with a
pause of approximately 4.5 s between them. The intensity of particles is 106 per
spill. The spots are irradiated with a dose driven method, when the desired dose
value is reached the beam is displaced to the next spot.
7.2 Measurements Description
In order to perform the measurements the mini-TEPC was inserted in a phantom
made of a PMMA box filled with water, with the entrance window placed perpendic-
ularly to the beam direction. The mini-TEPC was housed inside a Lucite support,
that in turn is fixed to a movable rod connected to the PMMA box. The water
phantom with the detector is shown in Figure 7.4, together with the .
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Figure 7.3: Schematic drawing of the spatial characteristics of the field. Each square represents a voxel, the
irradiation spot is at its center. The blue circle indicates the transversal extension of the beam, covering
more than one spot at each irradiation step. The red square indicates the detector position in the phantom,
and the points indicate the spots contributing to the SV irradiation.
The measurements are performed in an actual treatment room at the CNAO facility.
The adopted experimental setup is shown in Figure 7.5.
The microdosimetric measurements were performed at different water equivalent
depths, by simulating a tissue-equivalent size is 1 µm with pure propane. As shown
in the previous sections, this corresponds to a gas pressure of PC3H8 = 454 mbar.
At each position, it was chosen to collect the microdosimetric spectra at two dis-
tinct voltage differences between the electrodes of the SV, as suggested from the
previous experience in the high-LET neutron fields. Due to the limited measuring
time available, the acquisition with two voltages was not performed for all depths.
The complete set of measurements together with the applied voltages is presented
in Table 7.1 and in Figure 7.6.
Distance from isocenter [mm] DDP position [mm] Voltage [V]
48.5 40.2 600, 750
68.5 60.2 600, 750
83.3 75 600, 750
84.3 76 600
85.4 77 600, 750
86 77.7 600, 750
86.6 78.3 600, 750
Table 7.1: Set of measurements performed at CNAO. The left column indicates the position of the sensitive
volume in the water phantom, with respect to the isocenter. The middle column shows the equivalent
position of the detector in the depth-dose profile with the double ripple filter, shown in Figure 7.2.
The setup and optimization of the electronic chain was carried out by performing
the steps described in the previous sections.
In order to optimize the time available to perform the measurements and to have a
reliable estimate of the counting rate in the detector, it was planned to use an Ether-
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Figure 7.4: Picture showing the water phantom irradiated with the CNAO carbon beam, where the detector
position in emphasized.
net cable for the remote control of the acquisition PC, placed in the treatment room.
In this condition the electronic noise caused an obscuration of the first 1150 chan-
nels of the 14-bits ADC. The remote control of the acquisition computer was then
performed using the internal LAN network of the CNAO facility. In this condition
the noise level covered the first 740 ADC channels of the 14-bits ADC. To further
reduce the electronic noise contribution it was then chosen to operate by manually
starting and stopping the acquisition between each measurement. With this choice
the electronic noise level was reduced to 300 channels. The noise level measured
by means of the oscilloscope was approximately 600 µV at the preamplifier output.
The shaping time of the amplifiers was set to 250 ns. During the measurement shift
the constancy of the ADC calibration has been repeatedly checked.
7.3 Results
The spectra acquired with the two different voltages were joined together after the
identification of a proper superposition region at 100 keV/µm. The collected micro-
dosimetric spectra calibrated in lineal energy, are shown in Figure 7.7.
The lineal energy calibration has been performed by using the carbon edge region in
the pulse height spectra, which is evident at a water equivalent depth of 77.7 mm.
This is fitted with a Fermi function and used as reference for the energy calibra-
tion of the spectra. The carbon edge has been assigned to the lineal energy of
1397 keV/µm, corresponding to the maximum energy released in 1 µm of liquid
water [?].
The shape of the microdosimetric spectra, hence the dose fraction imparted in same
lineal energy intervals, strongly varies with depth, the contribution of high-LET
events strongly increasing in the Bragg peak region.
For the two spectra collected before the Bragg peak, the fast carbon ions cross the
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Figure 7.5: Picture showing the CNAO treatment room in which the measurements were performed.
The height of the treatment bed is adjusted so that the isocenter position matches the detector SV. The
electronic modules for data processing are placed on the left.
SV by releasing just part of their energy inside it. This energy deposition modality
constitutes the 92% of the absorbed dose for those depths.
The carbon peak shifts to higher energy values with increasing depth, until the car-
bon edge is reached. At a depth of 77.7 mm the carbon edge is evident, and the
relative importance of high-LET events begins to increase.
Nuclear reactions occurring in the energy range of interest in hadron therapy have
been studied experimentally and through Monte Carlo simulations, e.g. in [66], [67],
[69], [70]. The most frequent nuclear reactions that carbons undergo are peripheral
collisions with the target atoms, namely the carbons constituting the tissue equiva-
lent plastic of the counter walls. These interactions result in the projectile breakup,
giving a mixed field of secondary charged (from Z=5 to Z=1) and neutral (fast neu-
trons) particles, which contribute to an energy deposition beyond the Bragg peak,
and with a broad angular distribution. Monte Carlo simulations [67] suggest that
the major dose contribution just behind the Bragg peak is due to boron fragments.
At higher depths hydrogen and helium fragments constitute the major component,
due to their longest range.
Due to these facts low-LET events become dominant in the distal part after the
Bragg peak. In particular, two peaks arise in the dose distribution at 10 keV/µm
and 50 keV/µm, the former attributed to energy depositions from protons and α
particles, the latter from α and boron ions.
In order to verify the consistency between experimental and calculated data, Monte
Carlo simulations with the transport code FLUKA, have been performed ??. Figure
E. Motisi - Development of Microdosimetric Techniques Applied to Hadron Therapy 61
Figure 7.6: Investigated positions with reference to the enlarged depth-dose profile.
7.8 shows the experimental spectrum corresponding to a water equivalent depth of
77.7 mm, and the calculated microdosimetric spectra for a fixed carbon beam tar-
geting the detector SV and when the same beam covers stochastically the irradiated
area of 3 × 3 cm2. For lineal energy values below 100 keV/µm the best approxi-
mation of the experimental microdosimetric distribution is obtained by using the
spatially varying carbon beam. This shows that energy deposition events taking
place in the transversal direction with respect to the primary carbon beam give rise
to a non negligible low-LET events contribution inside the counter.
The microdosimetric spectra can be used to assess the actual absorbed dose in the
sensitive volume of the detector. For a cylindrical sensitive volume with height and
diameter equal to d the relation between the single-event imparted energy and the
lineal energy, for a simulated material of density ρ = 1 g/cm3, is given by [48]
z[Gy] = 0.136[d(µm)]2y [keV/µm] . (7.1)
In a microscopic volume with a large number of events, the dose D is proportional
to y¯F , in fact
D[Gy] ∼ nz¯1F [Gy] = n 0.136[d(µm)]2 y¯F [keV/µm] , (7.2)
where n is the number of the events corresponding to the energy deposition events
giving rise to the specific energies with mean value D, while z¯1F is the first mo-
mentum of the single event imparted energy distribution. Multiplying the average
frequency lineal energy value for the number of events will thus give an indication
of the actual dose imparted in the microdosimeter.
In order to evaluate the y¯F values a first operation consists in the linear extrapola-
tion of the counts of the microdosimetric spectra from the measurement threshold
to the value of 0.01 keV/µm, considered as the threshold of ionizing events. The
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Figure 7.7: Microdosimetric spectra calibrated in lineal energy, for a 195.2 MeV/amu carbon ion beam at
different water-equivalent depths (in mm).
uncertainty in the y¯F values, including the extrapolation and the lineal energy con-
tribution, has been calculated as in [55].
The extrapolated lineal energy spectra are presented in Figure 7.9.
Since the microdosimetric spectra are normalized at unitary dose, the y¯F as a func-
tion of depth will have the same trend as the absorbed dose. In Figure 7.10 the y¯F
value corresponding to the the maximum of the depth-dose curve (y¯F ≈ 40 keV/µm),
has been set equal to 1. The other y¯F values are normalized to this maximum value.
The uncertainty associated with the position is ± 0.3 mm. It can be seen that the
y¯F values reproduce the trend of the absorbed dose profile, apart from an offset of
about 0.5 mm in the TEPC position.
This procedure shows that the use of microdosimetric data from measurements with
two different gas gain allow leads to consistent results.
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Figure 7.8: Experimental (red line) and simulated data, for a fixed (light blue line) and spatially varying
(blue line) 195.2 MeV/amu carbon ion beam hitting the detector sensitive volume, using the FLUKA
transport code, as in [68].
Figure 7.9: Extrapolated microdosimetric spectra calibrated in lineal energy, for a 195.2 MeV/amu carbon
ion beam at different water-equivalent depths (in mm).
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Figure 7.10: Relative values of y¯F with error bars for a 195.2 MeV/amu carbon ion beam at different
water-equivalent depths.
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8. Conclusions
The response of new mini-TEPC designed and built in at the LNL-INFN laborato-
ries has been tested in several irradiation fields.
Lineal energy distributions have been collected for a variety of simulated sizes em-
ploying pure propane as filling gas, both in high- and low-LET fields.
Experimental data show that for low-LET fields the microdosimetric spectra retain
the same shape with changes in the gas gain, apart from an improvement of the
lower energy size detectable.
At the moment it has been observed that for high-LET events the spectra shape
suffer a distortion when high gas gains are employed, while at lower applied voltages
in the counter the spectra shape retain the same shape. For this reason, in order to
work with a large range of event sizes (with ion and neutron beams), the best option
seems to acquire the microdosimetric distributions with two different gas gains. The
two spectra are joined oﬄine, in order to retain the information on the full lineal
energy range.
This method has been employed at the CNAO facility, investigating the response of
a pulsed carbon ion beam employed in radiation therapy. A sign of the consistency
of this method is given by the evaluation of the dose imparted in the microdosime-
ter, which conforms to the dosimetric measurements performed for the same beam.
For the interpretation of the dose contribution due to the low-LET fragments pro-
duced by the carbon fragmentation, the experimental data have been compared with
Monte Carlo simulations.
The CNAO measurements are among the first microdosimetric measurements per-
formed in therapeutic carbon ion beams. The results obtained will be useful in
the next scheduled measurement campaign which will investigate the mini-TEPC
response in the fixed carbon beam of the CATANA facility at LNS-INFN. Micro-
dosimetric measurements will be compared to the carbon data collected at CNAO,
and will give an insight on the difference between the mini-TEPC response in fixed
and pulsed beams.
The data analysis has been performed with a software having a graphical user inter-
face written in C++, which allows to perform a quick spectra calibration and the
calculation of the microdosimetric distributions, optimizing the elaboration time. Its
further development is planned, with the extension of the number of implemented
algorithms tailored for mini-TEPC applications.
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A. C++ sources
A.1 Linear Regression
void lin_regr(int dim, double x[], double y[], double &intercept, double &slope, double
&sigma_intercept, double &sigma_slope, double &sigma_y){
double sum_x=0., sum_x2=0., sum_y=0., sum_xy=0.;
for(int i=0;i<dim;i++){
sum_x+=x[i];
sum_x2+=pow(x[i],2.);
sum_y+=y[i];
sum_xy+=x[i]*y[i];
}
double Delta=dim*sum_x2-pow(sum_x,2.);
intercept=(sum_x2*sum_y-sum_x*sum_xy)/Delta;
slope=(dim*sum_xy-sum_x*sum_y)/Delta;
double denominator_sigma_y=0.;
for(int i=0; i<dim; i++){
denominator_sigma_y+=pow(intercept+slope*x[i]-y[i],2.);
}
sigma_y=sqrt(denominator_sigma_y/(dim-2));
sigma_intercept=sigma_y*sqrt(sum_x2/Delta);
sigma_slope=sigma_y*sqrt(dim/Delta);
return;
}
A.2 Calibration and Rebinning
int calib_and_comp(string nomefile, string workdir, long double int_LL, long double
slo_LL, long double int_ML, long double slo_ML, long double int_HL, long double
slo_HL, int no_intervals, long double y_min)
{
char inputfile[400], outputfileLL[400], outputfileML[400], outputfileHL[400];
strcpy(inputfile, nomefile.c_str());
int B = no_intervals; //numero intervallini per decade
long double LL[16384], ML[16384], HL[16384];
for(int i=0;i<16384;i++){LL[i]=0., ML[i]=0., HL[i]=0.;}
ifstream InputFile;
InputFile.open(inputfile);
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if (!InputFile) {return 0;}
char empty1, empty2, empty3;
InputFile >> empty1 >> empty2 >> empty3;
double empty4, empty5, empty6;
InputFile >> empty4 >> empty5 >> empty6;
//LETTURA DEL FILE IN INPUT E INIZIALIZZAZIONE DEGLI ARRAY
for(int i=0;i<16384;i++) {
InputFile >> LL[i];
InputFile >> ML[i];
InputFile >> HL[i];
}
InputFile.close();
/************************************************************************************************/
//CALIBRAZIONE DEI CANALI IN mV
long double mV_LL[16384], mV_ML[16384], mV_HL[16384];
for(int i=0;i<16384;i++){
mV_LL[i]=int_LL+(i+1)*slo_LL;
mV_ML[i]=int_ML+(i+1)*slo_ML;
mV_HL[i]=int_HL+(i+1)*slo_HL;
}
/************************************************************************************************/
//SETTAGGIO DEGLI ESPONENTI DI 10 MINIMO E MASSIMO DELLO SPETTRO MICRODOSIMETRICO
long double min_mV=y_min, max_mV=1.;
for(int i=0;i<16384;i++) {
//if(mV_LL[i]<min_mV && mV_LL[i]>0.){min_mV=mV_LL[i];}
if(mV_LL[i]>max_mV){max_mV=mV_LL[i];}
if(mV_ML[i]>max_mV){max_mV=mV_ML[i];}
if(mV_HL[i]>max_mV){max_mV=mV_HL[i];}
}
int e_min, e_max;
{ long double temp1=log10(min_mV); e_min=floor(temp1);
long double temp2=log10(max_mV); e_max=floor(temp2+1.);}
int N=e_max-e_min; //numero di decadi
//SETTAGGIO DEGLI ESTREMI DELLE DECADI
long double y0[N+1];
for(int i=0;i<N+1;i++){y0[i]=pow(10,e_min+i);}
/************************************************************************************************/
//DEFINIZIONE DEGLI ARRAY PER IL COMPATTAMENTO E INIZIALIZZAZIONE A ZERO
int size=N*B;
double y_comp[size], N_LL[size], N_ML[size], N_HL[size];
for(int i=0;i<size;i++){y_comp[i]=0., N_LL[i]=0., N_ML[i]=0., N_HL[i]=0.;}
//CALCOLO DELLE y COMPATTATE
for(int j=0;j<N;j++){for(int i=j*B;i<(j+1)*B;i++){
double a=i*1., b=j*1., c=B*1., exp=(a-b*c)/c;
y_comp[i]=y0[j]*pow(10.,exp);
}}
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//CALCOLO DEGLI INTERVALLI DELTA_y
double Dy[size];
for(int i=0;i<size;i++){Dy[i]=0.;}
for(int i=0;i<size;i++){Dy[i]=y_comp[i]*(pow(10,0.5/B)-pow(10,-0.5/B));}
//COUNTERS
int counter_LL[size], counter_ML[size], counter_HL[size];
for(int i=0;i<size;i++){counter_LL[i]=0, counter_ML[i]=0, counter_HL[i]=0;}
//REBINNING DELLE ORDINATE
for(int i=0;i<16384;i++){
if(mV_LL[i]!=0.&&LL[i]!=0.){
for(int j=0;j<size;j++){
double Delta_inf, Delta_sup;
if(j==0){Delta_inf=0.;} else {Delta_inf=(y_comp[j]-y_comp[j-1])*0.5;}
if(j==size-1){Delta_sup=0.;} else {Delta_sup=(y_comp[j+1]-y_comp[j])*0.5;}
if(mV_LL[i]>=y_comp[j]-Delta_inf && mV_LL[i]<y_comp[j]+Delta_sup){N_LL[j]+=LL[i];}
}}}
for(int i=0;i<16384;i++){
if(mV_ML[i]!=0.&&ML[i]!=0.){
for(int j=0;j<size;j++){
double Delta_inf, Delta_sup;
if(j==0){Delta_inf=0.;} else {Delta_inf=(y_comp[j]-y_comp[j-1])*0.5;}
if(j==size-1){Delta_sup=0.;} else {Delta_sup=(y_comp[j+1]-y_comp[j])*0.5;}
if(mV_ML[i]>=y_comp[j]-Delta_inf && mV_ML[i]<y_comp[j]+Delta_sup){N_ML[j]+=ML[i];}
}}}
for(int i=0;i<16384;i++){
if(mV_HL[i]!=0.&&HL[i]!=0.){
for(int j=0;j<size;j++){
double Delta_inf, Delta_sup;
if(j==0){Delta_inf=0.;} else {Delta_inf=(y_comp[j]-y_comp[j-1])*0.5;}
if(j==size-1){Delta_sup=0.;} else {Delta_sup=(y_comp[j+1]-y_comp[j])*0.5;}
if(mV_HL[i]>=y_comp[j]-Delta_inf && mV_HL[i]<y_comp[j]+Delta_sup){N_HL[j]+=HL[i];}
}}}
for(int i=0;i<16384;i++){
for(int j=1;j<size-1;j++){
if(mV_LL[i]>=y_comp[j]-(y_comp[j]-y_comp[j-1])*0.5 &&
mV_LL[i]<y_comp[j]+(y_comp[j+1]-y_comp[j])*0.5) counter_LL[j]++;
if(mV_ML[i]>=y_comp[j]-(y_comp[j]-y_comp[j-1])*0.5 &&
mV_ML[i]<y_comp[j]+(y_comp[j+1]-y_comp[j])*0.5) counter_ML[j]++;
if(mV_HL[i]>=y_comp[j]-(y_comp[j]-y_comp[j-1])*0.5 &&
mV_HL[i]<y_comp[j]+(y_comp[j+1]-y_comp[j])*0.5) counter_HL[j]++;
}
}
//CALCOLO MEDIE
double average_LL[size], average_ML[size], average_HL[size];
for(int i=0;i<size;i++){average_LL[i]=0., average_ML[i]=0., average_HL[i]=0.;}
for(int i=0;i<size;i++){
if(counter_LL[i]!=0.) average_LL[i]=N_LL[i]/counter_LL[i];
if(counter_ML[i]!=0.) average_ML[i]=N_ML[i]/counter_ML[i];
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if(counter_HL[i]!=0.) average_HL[i]=N_HL[i]/counter_HL[i];
}
//SCALING
for(int i=0;i<size;i++){
double temp1=average_ML[i]; average_ML[i]=(slo_LL/slo_ML)*temp1;
double temp2=average_HL[i]; average_HL[i]=(slo_LL/slo_HL)*temp2;
}
//NORMALIZZAZIONE DELLE ORDINATE
double n_LL[size], n_ML[size], n_HL[size];
for(int i=0;i<size;i++){n_LL[i]=0., n_ML[i]=0., n_HL[i]=0.;}
for(int i=0;i<size;i++){
if(Dy[i]!=0.){n_LL[i]=average_LL[i]/Dy[i];}
if(Dy[i]!=0.){n_ML[i]=average_ML[i]/Dy[i];}
if(Dy[i]!=0.){n_HL[i]=average_HL[i]/Dy[i];}
}
double total_events_LL=0., total_events_ML=0., total_events_HL=0.;
for(int i=0;i<size;i++){total_events_LL+=average_LL[i], total_events_ML+=average_ML[i],
total_events_HL+=average_HL[i];}
//CALCOLO DISTRIBUZIONE IN FREQUENZA
double f_LL[size], f_ML[size], f_HL[size];
for(int i=0;i<size;i++){f_LL[i]=0., f_ML[i]=0., f_HL[i]=0.;}
double normalization_f_LL=0., normalization_f_ML=0., normalization_f_HL=0.;
for(int i=0;i<size;i++){normalization_f_LL+=average_LL[i]*Dy[i],
normalization_f_ML+=average_ML[i]*Dy[i], normalization_f_HL+=average_HL[i]*Dy[i];}
for(int i=0;i<size;i++){f_LL[i]=average_LL[i]/normalization_f_LL,
f_ML[i]=average_ML[i]/normalization_f_ML, f_HL[i]=average_HL[i]/normalization_f_HL;}
/*Codice x verifica normalizzazione della distribuzione f(y)*/
//double sum_f_LL=0., sum_f_ML=0., sum_f_HL=0.;
//for(int i=0;i<size;i++){sum_f_LL+=f_LL[i]*Dy[i], sum_f_ML+=f_ML[i]*Dy[i],
sum_f_HL+=f_HL[i]*Dy[i];}
//qDebug() << sum_f_LL << " - " << sum_f_ML << " - " << sum_f_HL;
//CALCOLO ERRORI
double sigma_average_LL[size], sigma_average_ML[size], sigma_average_HL[size];
for(int i=0;i<size;i++){sigma_average_LL[i]=0., sigma_average_ML[i]=0.,
sigma_average_HL[i]=0.;}
for(int i=0;i<size;i++){
if(counter_LL[i]!=0.) sigma_average_LL[i]=sqrt(average_LL[i]);
if(counter_ML[i]!=0.) sigma_average_ML[i]=sqrt(average_ML[i]);
if(counter_HL[i]!=0.) sigma_average_HL[i]=sqrt(average_HL[i]);
}
double sigma_n_LL[size], sigma_n_ML[size], sigma_n_HL[size];
for(int i=0;i<size;i++){sigma_n_LL[i]=0., sigma_n_ML[i]=0., sigma_n_HL[i]=0.;}
/*vecchi errori n[i]*/
for(int i=0;i<size;i++){
if(counter_LL[i]!=0.) sigma_n_LL[i]=sqrt(n_LL[i]/Dy[i]);
if(counter_ML[i]!=0.) sigma_n_ML[i]=sqrt(n_ML[i]/Dy[i]);
if(counter_HL[i]!=0.) sigma_n_HL[i]=sqrt(n_HL[i]/Dy[i]);
}
//SCRITTURA DEL FILE DI OUTPUT
string outfileLL=workdir+"/LL_calibrated.txt";
strcpy(outputfileLL, outfileLL.c_str());
ofstream OutputFileLL;
OutputFileLL.open(outputfileLL);
for(int i=0;i<size;i++) {
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OutputFileLL << y_comp[i] << " " << N_LL[i] << " " << counter_LL[i] << " " <<
average_LL[i] << " " << sigma_average_LL[i] << " " << n_LL[i] << " " <<
sigma_n_LL[i] << endl;
}
OutputFileLL.close();
string outfileML=workdir+"/ML_calibrated.txt";
strcpy(outputfileML, outfileML.c_str());
ofstream OutputFileML;
OutputFileML.open(outputfileML);
for(int i=0;i<size;i++) {
OutputFileML << y_comp[i] << " " << N_ML[i] << " " << counter_ML[i] << " " <<
average_ML[i] << " " << sigma_average_ML[i] << " " << n_ML[i] << " " <<
sigma_n_ML[i] << endl;
}
OutputFileML.close();
string outfileHL=workdir+"/HL_calibrated.txt";
strcpy(outputfileHL, outfileHL.c_str());
ofstream OutputFileHL;
OutputFileHL.open(outputfileHL);
for(int i=0;i<size;i++) {
OutputFileHL << y_comp[i] << " " << N_HL[i] << " " << counter_HL[i] << " " <<
average_HL[i] << " " << sigma_average_HL[i] << " " << n_HL[i] << " " <<
sigma_n_HL[i] << endl;
}
OutputFileHL.close();
return N;
}
A.3 Determination of the Cut Point
int giunta_2(std::string workdir, double y_min_1, double y_max_1, bool scalingLL, bool
scalingLL_ML){
char inputfileLL[400],inputfileML[400];
string infileLL=workdir+"/LL_calibrated.txt";
strcpy(inputfileLL, infileLL.c_str());
string infileML=workdir+"/ML_calibrated.txt";
if(scalingLL_ML==1){infileML=workdir+"/ML_calibrated_new.txt";}
strcpy(inputfileML, infileML.c_str());
//LETTURA DIMENSIONE DEGLI ARRAY
ifstream InLL;
InLL.open(inputfileLL);
if (!InLL) {return 0;}
string sLL;
int DIMLL=0;
while(!InLL.eof()){getline(InLL,sLL,’\n’);DIMLL++;}
InLL.close();
ifstream InML;
InML.open(inputfileML);
if (!InML) {return 0;}
string sML;
int DIMML=0;
while(!InML.eof()){getline(InML,sML,’\n’);DIMML++;}
InML.close();
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//LETTURA DEL FILE IN INPUT E INIZIALIZZAZIONE DEGLI ARRAY
ifstream InputFileLL;
InputFileLL.open(inputfileLL);
double y_mV[DIMLL-1], N_LL[DIMLL-1], counter_LL[DIMLL-1], average_LL[DIMLL-1],
sigma_average_LL[DIMLL-1], n_LL[DIMLL-1], sigma_n_LL[DIMLL-1];
for(int i=0;i<DIMLL-1;i++){
InputFileLL >> y_mV[i] >> N_LL[i] >> counter_LL[i] >> average_LL[i] >>
sigma_average_LL[i] >> n_LL[i] >> sigma_n_LL[i];
}
InputFileLL.close();
ifstream InputFileML;
InputFileML.open(inputfileML);
double N_ML[DIMML-1], counter_ML[DIMML-1], average_ML[DIMML-1],
sigma_average_ML[DIMML-1], n_ML[DIMML-1], sigma_n_ML[DIMML-1];
for(int i=0;i<DIMML-1;i++){
InputFileML >> y_mV[i] >> N_ML[i] >> counter_ML[i] >> average_ML[i] >>
sigma_average_ML[i] >> n_ML[i] >> sigma_n_ML[i];
}
InputFileML.close();
//IDENTIFICAZIONE DELLE REGIONI DI SOVRAPPOSIZIONE SCELTE DALL’UTENTE
int N_1=0, min_1=0, max_1=0;
for(int i=0;i<DIMLL-2;i++){
if(y_mV[i]<=y_min_1) min_1=i+1;
if(y_mV[i]>y_min_1 && y_mV[i]<=y_max_1) max_1=i;
}
N_1=max_1-min_1+1;
// CALCOLO COEFFICIENTI DEL FIT LINEARE DEI DATI
double x[N_1], yLL[N_1], yML[N_1], sigma_yLL[N_1], sigma_yML[N_1];
for(int i=0;i<N_1;i++){
x[i]=log10(y_mV[min_1+i]);
yLL[i]=log10(average_LL[min_1+i]);
yML[i]=log10(average_ML[min_1+i]);
}
double intLL=0., sloLL=0., sigma_intLL=0., sigma_sloLL=0., devLL=0.;
double intML=0., sloML=0., sigma_intML=0., sigma_sloML=0., devML=0.;
lin_regr(N_1, x, yLL, intLL, sloLL, sigma_intLL, sigma_sloLL, devLL);
lin_regr(N_1, x, yML, intML, sloML, sigma_intML, sigma_sloML, devML);
// CALCOLO COMPATIBILITA’ PENDENZE
double comp1=0.;
if(sloML>sloLL)
comp1=(sloML-sloLL)*pow(sigma_sloLL*sigma_sloLL+sigma_sloML*sigma_sloML,-0.5);
if(sloML<sloLL)
comp1=-(sloML-sloLL)*pow(sigma_sloLL*sigma_sloLL+sigma_sloML*sigma_sloML,-0.5);
qDebug() << "********";
qDebug() << sloLL << "+/-" << sigma_sloLL;
qDebug() << sloML << "+/-" << sigma_sloML;
qDebug() << "********";
//VALORI DEI CONTEGGI DAI FIT
double fit_LL[N_1], fit_ML[N_1];
for(int i=0;i<N_1;i++){
fit_LL[i]=pow(10.,intLL+sloLL*x[i]);
fit_ML[i]=pow(10.,intML+sloML*x[i]);
}
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char junct1[400];
string out1=workdir+"/fit_junction_1.txt";
strcpy(junct1, out1.c_str());
ofstream OutputJunct1;
OutputJunct1.open(junct1);
OutputJunct1 << intLL << " " << sloLL << " " << devLL << intML << " " << sloML << " " <<
devML << " " << comp1 << endl;
for(int i=0;i<N_1;i++){
OutputJunct1 << y_mV[min_1+i] << " " << average_LL[min_1+i] << " " << fit_LL[i] << "
" << y_mV[min_1+i] << " " << average_ML[min_1+i] << " " << fit_ML[i] << endl;
}
OutputJunct1.close();
/************************************************************************************************/
if(scalingLL==1 || scalingLL_ML==1){
for(int i=0;i<DIMLL-1;i++){
double exp1=intML+(sloML/sloLL)*(log10(n_LL[i])-intLL);
n_LL[i]=pow(10.,exp1);
double exp2=intML+(sloML/sloLL)*(log10(average_LL[i])-intLL);
average_LL[i]=pow(10.,exp2);
}
char out_LL_new[400];
string out=workdir+"/LL_calibrated_new.txt";
strcpy(out_LL_new, out.c_str());
ofstream Output_LL_new;
Output_LL_new.open(out_LL_new);
for(int i=0;i<DIMLL-1;i++){
Output_LL_new << y_mV[i] << " " << N_LL[i] << " " << counter_LL[i] << " " <<
average_LL[i] << " " << sigma_average_LL[i] << " " << n_LL[i] << " " <<
sigma_n_LL[i] << endl;
}
Output_LL_new.close();
}
//CALCOLO DIFFERENZE RELATIVE TRA SERIE DATI IN LOGARITMICO
double diff_log[N_1];
for(int i=0;i<N_1;i++) {
double a=sloLL*x[i]+intLL;
double b=sloML*x[i]+intML;
diff_log[i]=(1.-b/a);
}
//ARRAY CON GLI ERRORI SULLE DIFFERENZE IN LOGARITMICO
double sigma_diff_log[N_1];
for(int i=0;i<N_1;i++){sigma_diff_log[i]=0.;}
for(int i=0;i<N_1;i++){
double a=sloLL*x[i]+intLL;
double b=sloML*x[i]+intML;
double var_a=pow(sigma_sloLL*x[i],2.)+pow(sigma_intLL,2.);
double var_b=pow(sigma_sloML*x[i],2.)+pow(sigma_intML,2.);
sigma_diff_log[i]=pow(b*b*var_a/(a*a)+var_b,0.5)/a;
}
//CALCOLO DIFFERENZE RELATIVE TRA SERIE DATI IN LINEARE
double diff[N_1];
for(int i=0;i<N_1;i++) {
double a=sloLL*x[i]+intLL;
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diff[i]=1.-pow(10.,-diff_log[i]*a);
}
//ARRAY CON GLI ERRORI SULLE DIFFERENZE IN LINEARE
double sigma_diff[N_1];
for(int i=0;i<N_1;i++){sigma_diff[i]=0.;}
for(int i=0;i<N_1;i++){
double a=sloLL*x[i]+intLL;
double var_a=pow(sigma_sloLL*x[i],2.)+pow(sigma_intLL,2.);
sigma_diff[i]=pow(a*a*sigma_diff_log[i]*sigma_diff_log[i]+diff_log[i]*diff_log[i]*var_a,0.5)*log(10.);
}
//CALCOLO MEDIA PESATA DELLE DIFFERENZE TRA CONTEGGI
double sum_weights=0., num=0.;
double sigma_diff_counts[N_1];
for(int i=0;i<N_1;i++){sigma_diff_counts[i]=0.;}
for(int i=0;i<N_1;i++){
sigma_diff_counts[i]=sqrt(sigma_average_LL[min_1+i]*sigma_average_LL[min_1+i]
+sigma_average_ML[min_1+i]*sigma_average_ML[min_1+i]*average_LL[min_1+i]*average_LL[min_1+i]/
(average_ML[min_1+i]*average_ML[min_1+i]))/average_ML[min_1+i];
}
for(int i=0;i<N_1;i++){sum_weights+=pow(sigma_diff_counts[i],-2.);}
for(int
i=0;i<N_1;i++){num+=(1.-average_LL[min_1+i]/average_ML[min_1+i])*pow(sigma_diff_counts[i],-2.);}
double weighted_mean=num/sum_weights;
double sigma_mean=pow(sum_weights,-0.5);
qDebug() << "Media pesata campione 1:" << weighted_mean << "+/-" << sigma_mean;
//CALCOLO VARIANZA CAMPIONE DELLE DIFFERENZE TRA CONTEGGI
double single_var[N_1];
for(int
i=0;i<N_1;i++){single_var[i]=pow((1.-average_LL[min_1+i]/average_ML[min_1+i])-weighted_mean,2.);}
double num_var=0.;
for(int i=0;i<N_1;i++){num_var+=single_var[i];}
double den_var=(N_1*1.-1.);
double var_sample=num_var/den_var;
qDebug() << "Varianza pesata campione 1:" << var_sample;
//CALCOLO DEI PUNTI DI TAGLIO, REGIONE DI MINIMO
double medie_var[N_1];
medie_var[0]=(single_var[0]+single_var[1]+single_var[2])/3.;
medie_var[1]=(single_var[0]+single_var[1]+single_var[2]+single_var[3])/4.;
medie_var[N_1-2]=(single_var[N_1-1]+single_var[N_1-2]+single_var[N_1-3]+single_var[N_1-4])/4.;
medie_var[N_1-1]=(single_var[N_1-1]+single_var[N_1-2]+single_var[N_1-3])/3.;
for(int i=2;i<N_1-2;i++){
medie_var[i]=(single_var[i-2]+single_var[i-1]+single_var[i]+single_var[i+1]+single_var[i+2])/5.;
}
double min_var=medie_var[0], y_min_var=y_mV[min_1];
int index_min_var=0;
for(int i=0;i<N_1;i++){
if(medie_var[i]<=min_var){min_var=medie_var[i], index_min_var=i;}
}
y_min_var=y_mV[min_1+index_min_var];
char outputvar1[400];
string outvar1=workdir+"/variances1.txt";
strcpy(outputvar1, outvar1.c_str());
ofstream OutputFileVar1;
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OutputFileVar1.open(outputvar1);
OutputFileVar1 << y_min_var << " " << var_sample << endl;
for(int i=0;i<N_1;i++){
OutputFileVar1 << y_mV[min_1+i] << " " << single_var[i]/(var_sample*den_var) << endl;
}
OutputFileVar1.close();
return DIMLL;
}
int giunta_3(std::string workdir, double y_min_2, double y_max_2, bool scalingLL_ML){
char inputfileML[400],inputfileHL[400];
string infileML=workdir+"/ML_calibrated.txt";
strcpy(inputfileML, infileML.c_str());
string infileHL=workdir+"/HL_calibrated.txt";
strcpy(inputfileHL, infileHL.c_str());
//LETTURA DIMENSIONE DEGLI ARRAY
ifstream InML;
InML.open(inputfileML);
if (!InML) {return 0;}
string sML;
int DIMML=0;
while(!InML.eof()){getline(InML,sML,’\n’);DIMML++;}
InML.close();
ifstream InHL;
InHL.open(inputfileHL);
if (!InHL) {return 0;}
string sHL;
int DIMHL=0;
while(!InHL.eof()){getline(InHL,sHL,’\n’);DIMHL++;}
InHL.close();
//LETTURA DEL FILE IN INPUT E INIZIALIZZAZIONE DEGLI ARRAY
ifstream InputFileML;
InputFileML.open(inputfileML);
double y_mV[DIMML-1], N_ML[DIMML-1], counter_ML[DIMML-1], average_ML[DIMML-1],
sigma_average_ML[DIMML-1], n_ML[DIMML-1], sigma_n_ML[DIMML-1];
for(int i=0;i<DIMML-1;i++){
InputFileML >> y_mV[i] >> N_ML[i] >> counter_ML[i] >> average_ML[i] >>
sigma_average_ML[i] >> n_ML[i] >> sigma_n_ML[i];
}
InputFileML.close();
ifstream InputFileHL;
InputFileHL.open(inputfileHL);
double N_HL[DIMHL-1], counter_HL[DIMHL-1], average_HL[DIMHL-1],
sigma_average_HL[DIMHL-1], n_HL[DIMHL-1], sigma_n_HL[DIMHL-1];
for(int i=0;i<DIMHL-1;i++){
InputFileHL >> y_mV[i] >> N_HL[i] >> counter_HL[i] >> average_HL[i] >>
sigma_average_HL[i] >> n_HL[i] >> sigma_n_HL[i];
}
InputFileHL.close();
//IDENTIFICAZIONE DEMLE REGIONI DI SOVRAPPOSIZIONE SCELTE DALL’UTENTE
int N_1=0, min_1=0, max_1=0;
for(int i=0;i<DIMHL-2;i++){
if(y_mV[i]<=y_min_2) min_1=i+1;
if(y_mV[i]>y_min_2 && y_mV[i]<=y_max_2) max_1=i;
}
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N_1=max_1-min_1+1;
// CALCOLO COEFFICIENTI DEL FIT LINEARE DEI DATI
double x[N_1], yML[N_1], yHL[N_1], sigma_yML[N_1], sigma_yHL[N_1];
for(int i=0;i<N_1;i++){
x[i]=log10(y_mV[min_1+i]);
yML[i]=log10(average_ML[min_1+i]);
yHL[i]=log10(average_HL[min_1+i]);
}
double intML=0., sloML=0., sigma_intML=0., sigma_sloML=0., devML=0.;
double intHL=0., sloHL=0., sigma_intHL=0., sigma_sloHL=0., devHL=0.;
lin_regr(N_1, x, yML, intML, sloML, sigma_intML, sigma_sloML, devML);
lin_regr(N_1, x, yHL, intHL, sloHL, sigma_intHL, sigma_sloHL, devHL);
// CALCOLO COMPATIBILITA’ PENDENZE
double comp1=0.;
if(sloHL>sloML)
comp1=(sloHL-sloML)*pow(sigma_sloML*sigma_sloML+sigma_sloHL*sigma_sloHL,-0.5);
if(sloHL<sloML)
comp1=-(sloHL-sloML)*pow(sigma_sloML*sigma_sloML+sigma_sloHL*sigma_sloHL,-0.5);
qDebug() << "********";
qDebug() << sloML << "+/-" << sigma_sloML;
qDebug() << sloHL << "+/-" << sigma_sloHL;
qDebug() << "********";
//VALORI DEI CONTEGGI DAI FIT
double fit_ML[N_1], fit_HL[N_1];
for(int i=0;i<N_1;i++){
fit_ML[i]=pow(10.,intML+sloML*x[i]);
fit_HL[i]=pow(10.,intHL+sloHL*x[i]);
}
char junct1[400];
string out1=workdir+"/fit_junction_2.txt";
strcpy(junct1, out1.c_str());
ofstream OutputJunct1;
OutputJunct1.open(junct1);
OutputJunct1 << intML << " " << sloML << " " << devML << intHL << " " << sloHL << " " <<
devHL << " " << comp1 << endl;
for(int i=0;i<N_1;i++){
OutputJunct1 << y_mV[min_1+i] << " " << average_ML[min_1+i] << " " << fit_ML[i] << "
" << y_mV[min_1+i] << " " << average_HL[min_1+i] << " " << fit_HL[i] << endl;
}
OutputJunct1.close();
/************************************************************************************************/
if(scalingLL_ML==1){
for(int i=0;i<DIMML-1;i++){
double exp1=intHL+(sloHL/sloML)*(log10(n_ML[i])-intML);
n_ML[i]=pow(10.,exp1);
double exp2=intHL+(sloHL/sloML)*(log10(average_ML[i])-intML);
average_ML[i]=pow(10.,exp2);
}
char out_ML_new[400];
string out=workdir+"/ML_calibrated_new.txt";
strcpy(out_ML_new, out.c_str());
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ofstream Output_ML_new;
Output_ML_new.open(out_ML_new);
for(int i=0;i<DIMML-1;i++){
Output_ML_new << y_mV[i] << " " << N_ML[i] << " " << counter_ML[i] << " " <<
average_ML[i] << " " << sigma_average_ML[i] << " " << n_ML[i] << " " <<
sigma_n_ML[i] << endl;
}
Output_ML_new.close();
}
//CALCOLO DIFFERENZE RELATIVE TRA SERIE DATI IN LOGARITMICO
double diff_log[N_1];
for(int i=0;i<N_1;i++) {
double a=sloML*x[i]+intML;
double b=sloHL*x[i]+intHL;
diff_log[i]=(1.-b/a);
}
//ARRAY CON GLI ERRORI SULLE DIFFERENZE IN LOGARITMICO
double sigma_diff_log[N_1];
for(int i=0;i<N_1;i++){sigma_diff_log[i]=0.;}
for(int i=0;i<N_1;i++){
double a=sloML*x[i]+intML;
double b=sloHL*x[i]+intHL;
double var_a=pow(sigma_sloML*x[i],2.)+pow(sigma_intML,2.);
double var_b=pow(sigma_sloHL*x[i],2.)+pow(sigma_intHL,2.);
sigma_diff_log[i]=pow(b*b*var_a/(a*a)+var_b,0.5)/a;
}
//CALCOLO DIFFERENZE RELATIVE TRA SERIE DATI IN LINEARE
double diff[N_1];
for(int i=0;i<N_1;i++) {
double a=sloML*x[i]+intML;
diff[i]=1.-pow(10.,-diff_log[i]*a);
}
//ARRAY CON GLI ERRORI SULLE DIFFERENZE IN LINEARE
double sigma_diff[N_1];
for(int i=0;i<N_1;i++){sigma_diff[i]=0.;}
for(int i=0;i<N_1;i++){
double a=sloML*x[i]+intML;
double var_a=pow(sigma_sloML*x[i],2.)+pow(sigma_intML,2.);
sigma_diff[i]=pow(a*a*sigma_diff_log[i]*sigma_diff_log[i]
+diff_log[i]*diff_log[i]*var_a,0.5)*log(10.);
}
//CALCOLO MEDIA PESATA DELLE DIFFERENZE TRA CONTEGGI
double sum_weights=0., num=0.;
double sigma_diff_counts[N_1];
for(int i=0;i<N_1;i++){sigma_diff_counts[i]=0.;}
for(int i=0;i<N_1;i++){
sigma_diff_counts[i]=sqrt(sigma_average_ML[min_1+i]*sigma_average_ML[min_1+i]
+sigma_average_HL[min_1+i]*sigma_average_HL[min_1+i]*average_ML[min_1+i]*average_ML[min_1+i]
/(average_HL[min_1+i]*average_HL[min_1+i]))/average_HL[min_1+i];
}
for(int i=0;i<N_1;i++){sum_weights+=pow(sigma_diff_counts[i],-2.);}
for(int
i=0;i<N_1;i++){num+=(1.-average_ML[min_1+i]/average_HL[min_1+i])*pow(sigma_diff_counts[i],-2.);}
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double weighted_mean=num/sum_weights;
double sigma_mean=pow(sum_weights,-0.5);
qDebug() << "Media pesata campione 2:" << weighted_mean << "+/-" << sigma_mean;
//CALCOLO VARIANZA CAMPIONE DELLE DIFFERENZE TRA CONTEGGI
double single_var[N_1];
for(int
i=0;i<N_1;i++){single_var[i]=pow((1.-average_ML[min_1+i]/average_HL[min_1+i])-weighted_mean,2.);}
double num_var=0.;
for(int i=0;i<N_1;i++){num_var+=single_var[i];}
double den_var=(N_1*1.-1.);
double var_sample=num_var/den_var;
qDebug() << "Varianza pesata campione 2:" << var_sample;
//CALCOLO DEI PUNTI DI TAGLIO, REGIONE DI MINIMO
double medie_var[N_1];
medie_var[0]=(single_var[0]+single_var[1]+single_var[2])/3.;
medie_var[1]=(single_var[0]+single_var[1]+single_var[2]+single_var[3])/4.;
medie_var[N_1-2]=(single_var[N_1-1]+single_var[N_1-2]+single_var[N_1-3]+single_var[N_1-4])/4.;
medie_var[N_1-1]=(single_var[N_1-1]+single_var[N_1-2]+single_var[N_1-3])/3.;
for(int i=2;i<N_1-2;i++){
medie_var[i]=(single_var[i-2]+single_var[i-1]+single_var[i]+single_var[i+1]+single_var[i+2])/5.;
}
double min_var=medie_var[0], y_min_var=0.;
int index_min_var=0;
for(int i=0;i<N_1;i++){
if(medie_var[i]<=min_var){
min_var=medie_var[i];
index_min_var=i;
}}
y_min_var=y_mV[min_1+index_min_var];
char outputvar1[400];
string outvar1=workdir+"/variances2.txt";
strcpy(outputvar1, outvar1.c_str());
ofstream OutputFileVar1;
OutputFileVar1.open(outputvar1);
OutputFileVar1 << y_min_var << " " << var_sample << endl;
for(int i=0;i<N_1;i++){
OutputFileVar1 << y_mV[min_1+i] << " " << single_var[i]/(var_sample*den_var) << endl;
}
OutputFileVar1.close();
return DIMHL;
}
void join_spectra(std::string workdir, double cut12, double cut23, bool check2or3, bool
scalingLL, bool scalingLL_ML){
char inputfileLL[400],inputfileML[400],inputfileHL[400];
string infileLL;
if(scalingLL==0){infileLL=workdir+"/LL_calibrated.txt";}
if(scalingLL==1 || scalingLL_ML==1){infileLL=workdir+"/LL_calibrated_new.txt";}
strcpy(inputfileLL, infileLL.c_str());
string infileML;
if(scalingLL_ML==0){infileML=workdir+"/ML_calibrated.txt";}
if(scalingLL_ML==1){infileML=workdir+"/ML_calibrated_new.txt";}
strcpy(inputfileML, infileML.c_str());
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string infileHL=workdir+"/HL_calibrated.txt";
strcpy(inputfileHL, infileHL.c_str());
//LETTURA DIMENSIONE DEGLI ARRAY
ifstream InLL;
InLL.open(inputfileLL);
if (!InLL) {return;}
string sLL;
int DIMLL=0;
while(!InLL.eof()){getline(InLL,sLL,’\n’);DIMLL++;}
InLL.close();
ifstream InML;
InML.open(inputfileML);
if (!InML) {return;}
string sML;
int DIMML=0;
while(!InML.eof()){getline(InML,sML,’\n’);DIMML++;}
InML.close();
ifstream InHL;
InHL.open(inputfileHL);
if (!InHL) {return;}
string sHL;
int DIMHL=0;
while(!InHL.eof()){getline(InHL,sHL,’\n’);DIMHL++;}
InHL.close();
//LETTURA DEL FILE IN INPUT E INIZIALIZZAZIONE DEGLI ARRAY
ifstream InputFileLL;
InputFileLL.open(inputfileLL);
double y_mV[DIMLL-1], N_LL[DIMLL-1], counter_LL[DIMLL-1], average_LL[DIMLL-1],
sigma_average_LL[DIMLL-1], n_LL[DIMLL-1], sigma_n_LL[DIMLL-1];
for(int i=0;i<DIMLL-1;i++){
InputFileLL >> y_mV[i] >> N_LL[i] >> counter_LL[i] >> average_LL[i] >>
sigma_average_LL[i] >> n_LL[i] >> sigma_n_LL[i];
}
InputFileLL.close();
ifstream InputFileML;
InputFileML.open(inputfileML);
double N_ML[DIMML-1], counter_ML[DIMML-1], average_ML[DIMML-1],
sigma_average_ML[DIMML-1], n_ML[DIMML-1], sigma_n_ML[DIMML-1];
for(int i=0;i<DIMML-1;i++){
InputFileML >> y_mV[i] >> N_ML[i] >> counter_ML[i] >> average_ML[i] >>
sigma_average_ML[i] >> n_ML[i] >> sigma_n_ML[i];
}
InputFileML.close();
ifstream InputFileHL;
InputFileHL.open(inputfileHL);
double N_HL[DIMHL-1], counter_HL[DIMHL-1], average_HL[DIMHL-1],
sigma_average_HL[DIMHL-1], n_HL[DIMHL-1], sigma_n_HL[DIMHL-1];
for(int i=0;i<DIMHL-1;i++){
InputFileHL >> y_mV[i] >> N_HL[i] >> counter_HL[i] >> average_HL[i] >>
sigma_average_HL[i] >> n_HL[i] >> sigma_n_HL[i];
}
InputFileHL.close();
char outputfile[400];
string outfile=workdir+"/giunta.txt";
strcpy(outputfile, outfile.c_str());
ofstream OutputFile;
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OutputFile.open(outputfile);
if(check2or3==0){
for(int i=0;i<DIMLL-2;i++) {
if(y_mV[i]<=cut12){OutputFile << y_mV[i] << " " << N_LL[i] << " " << counter_LL[i]
<< " " << average_LL[i] << " " << sigma_average_LL[i] << " " << n_LL[i] << " "
<< sigma_n_LL[i] << endl;}
if(y_mV[i]>cut12){OutputFile << y_mV[i] << " " << N_ML[i] << " " << counter_ML[i]
<< " " << average_ML[i] << " " << sigma_average_ML[i] << " " << n_ML[i] << " "
<< sigma_n_ML[i] << endl;}
}
}
if(check2or3==1){
for(int i=0;i<DIMLL-2;i++) {
if(y_mV[i]<=cut12){OutputFile << y_mV[i] << " " << N_LL[i] << " " << counter_LL[i]
<< " " << average_LL[i] << " " << sigma_average_LL[i] << " " << n_LL[i] << " "
<< sigma_n_LL[i] << endl;}
if(y_mV[i]>cut12 && y_mV[i]<=cut23){OutputFile << y_mV[i] << " " << N_ML[i] << " "
<< counter_ML[i] << " " << average_ML[i] << " " << sigma_average_ML[i] << " "
<< n_ML[i] << " " << sigma_n_ML[i] << endl;}
if(y_mV[i]>cut23){ OutputFile << y_mV[i] << " " << N_HL[i] << " " << counter_HL[i]
<< " " << average_HL[i] << " " << sigma_average_HL[i] << " " << n_HL[i] << " "
<< sigma_n_HL[i] << endl;}
}
}
OutputFile.close();
}
A.4 Microdosimetric Spectra and Uncertainties
int rebin(std::string workdir, int no_intervals, long double y_min, double total_counts){
char inputfile[400];
string infile=workdir+"/giunta.txt";
strcpy(inputfile, infile.c_str());
int B = no_intervals; //numero intervallini per decade
//LETTURA DIMENSIONE DEGLI ARRAY
ifstream In;
In.open(inputfile);
if (!In) {return 0;}
string s;
int DIM=0;
while(!In.eof()){getline(In,s,’\n’);DIM++;}
In.close();
//LETTURA DEL FILE IN INPUT E INIZIALIZZAZIONE DEGLI ARRAY
ifstream InputFile;
InputFile.open(inputfile);
double y_mV[DIM-1], N_old[DIM-1], counter_old[DIM-1], average_old[DIM-1],
sigma_average_old[DIM-1], n_old[DIM-1], sigma_n_old[DIM-1];
for(int i=0;i<DIM-1;i++){
InputFile >> y_mV[i] >> N_old[i] >> counter_old[i] >> average_old[i] >>
sigma_average_old[i] >> n_old[i] >> sigma_n_old[i];
}
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InputFile.close();
/************************************************************************************************/
//SETTAGGIO DEGLI ESPONENTI DI 10 MINIMO E MASSIMO DELLO SPETTRO MICRODOSIMETRICO
double min_mV=y_min, max_mV=1.;
for(int i=0;i<DIM;i++) {
if(y_mV[i]>max_mV){max_mV=y_mV[i];}
}
int e_min, e_max;
{ long double temp1=log10(min_mV); e_min=floor(temp1);
long double temp2=log10(max_mV); e_max=floor(temp2+1.);}
int Num=e_max-e_min; //numero di decadi
//SETTAGGIO DEGLI ESTREMI DELLE DECADI
long double y0[Num+1];
for(int i=0;i<Num+1;i++){y0[i]=pow(10,e_min+i);}
/************************************************************************************************/
//DEFINIZIONE DEGLI ARRAY PER IL COMPATTAMENTO E INIZIALIZZAZIONE A ZERO
int D=Num*B;
double y_comp[D], N[D];
for(int i=0;i<D;i++){y_comp[i]=0., N[i]=0.;}
//CALCOLO DELLE y COMPATTATE
for(int j=0;j<Num;j++){for(int i=j*B;i<(j+1)*B;i++){
double a=i*1., b=j*1., c=B*1., exp=(a-b*c)/c;
y_comp[i]=y0[j]*pow(10.,exp);
}}
//CALCOLO DEGLI INTERVALLI DELTA_y
double Dy[D];
for(int i=0;i<D;i++){Dy[i]=0.;}
for(int i=0;i<D;i++){Dy[i]=y_comp[i]*(pow(10,0.5/B)-pow(10,-0.5/B));}
//COUNTER
int counter[D];
for(int i=0;i<D;i++){counter[i]=0;}
//REBINNING DELLE ORDINATE
for(int i=0;i<DIM;i++){
if(y_mV[i]!=0.&&N_old[i]!=0.){
for(int j=0;j<D;j++){
double Delta_inf, Delta_sup;
if(j==0){Delta_inf=0.;} else {Delta_inf=(y_comp[j]-y_comp[j-1])*0.5;}
if(j==D-1){Delta_sup=0.;} else {Delta_sup=(y_comp[j+1]-y_comp[j])*0.5;}
if(y_mV[i]>=y_comp[j]-Delta_inf && y_mV[i]<y_comp[j]+Delta_sup){N[j]+=average_old[i];}
}}}
for(int i=0;i<DIM;i++){
for(int j=1;j<D-1;j++){
if(y_mV[i]>=y_comp[j]-(y_comp[j]-y_comp[j-1])*0.5 &&
y_mV[i]<y_comp[j]+(y_comp[j+1]-y_comp[j])*0.5) counter[j]++;
}
}
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//CALCOLO MEDIE
double average[D];
for(int i=0;i<D;i++){average[i]=0.;}
for(int i=0;i<D;i++){
if(counter[i]!=0.) average[i]=N[i]/counter[i];
}
//NORMALIZZAZIONE DELLE ORDINATE
double n[D];
for(int i=0;i<D;i++){n[i]=0.;}
for(int i=0;i<D;i++){
if(Dy[i]!=0.){n[i]=average[i]/Dy[i];}
}
//FATTORE DI NORMALIZZAZIONE PER LA DISTRIBUZIONE IN FREQUENZA
double norma_F=0.;
for(int i=0;i<D;i++){norma_F+=average[i]*Dy[i];}
//FATTORE DI NORMALIZZAZIONE PER LA DISTRIBUZIONE IN DOSE
double norma_D=0.;
for(int i=0;i<D;i++){norma_D+=average[i]*y_comp[i]*Dy[i];}
//CALCOLO DISTRIBUZIONE IN FREQUENZA
double f_y[D];
for(int i=0;i<D;i++){f_y[i]=average[i]/norma_F;}
//CALCOLO DISTRIBUZIONE IN DOSE
double d_y[D];
for(int i=0;i<D;i++){d_y[i]=y_comp[i]*average[i]/norma_D;}
/************************************************************************************************/
//SCRITTURA DEI FILES DI OUTPUT
char outputfile[400];
string outfile=workdir+"/giunta_compat.txt";
strcpy(outputfile, outfile.c_str());
ofstream OutputFile;
OutputFile.open(outputfile);
for(int i=0;i<D;i++) {
OutputFile << y_comp[i] << " " << N[i] << " " << average[i] << " " << Dy[i] << " "
<< f_y[i]
<< " " << d_y[i] << " " << y_comp[i]*f_y[i] << " " << y_comp[i]*d_y[i] <<
endl;
}
//VERIFICA DELLA NORMALIZZAZIONE DELLE DISTRIBUZIONI
double integr_F=0., integr_D=0.;
for(int i=0;i<D;i++) {integr_F+=Dy[i]*f_y[i]; integr_D+=Dy[i]*d_y[i];}
qDebug() << "Integrale in frequenza pari a " << integr_F << ", integrale in dose pari
a " << integr_D;
OutputFile.close();
/************************************************************************************************/
//CALCOLO ERRORI
double no_events=total_counts;
double sigma_average[D];
for(int i=0;i<D;i++){sigma_average[i]=0.;}
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for(int i=0;i<D;i++){
sigma_average[i]=sqrt(average[i]);
}
double sigma_n[D];
for(int i=0;i<D;i++){sigma_n[i]=0.;}
for(int i=0;i<D;i++){
if(Dy[i]!=0.) sigma_n[i]=sqrt(n[i]/Dy[i]);
}
double sigma_f_y[D], sigma_d_y[D], sigma_yf_y[D], sigma_yd_y[D];
for(int i=0;i<D;i++){sigma_f_y[i]=0., sigma_d_y[i]=0., sigma_yf_y[i]=0.,
sigma_yd_y[i]=0.;}
//nuovo sigma f(y)
for(int i=0;i<D;i++){sigma_f_y[i]=sqrt(f_y[i]/(Dy[i]*no_events));}
//nuovo sigma y*f(y)
for(int i=0;i<D;i++){sigma_yf_y[i]=sigma_f_y[i]*y_comp[i];}
//calcolo y_bar_F
double y_bar_F=0., sigma_y_bar_F=0., sum_for_sigma_y_bar_F=0.;
for(int i=0;i<D;i++){y_bar_F+=y_comp[i]*f_y[i]*Dy[i];}
for(int j=0;j<D;j++){
for(int i=0;i<D;i++){sum_for_sigma_y_bar_F+=pow(y_comp[i]*Dy[i]*sigma_f_y[i],2.);}
}
sigma_y_bar_F=sqrt(sum_for_sigma_y_bar_F);
qDebug() << "y_bar_F" << y_bar_F << "+/-" << sigma_y_bar_F;
double sum_for_sigma_d_y[D];
for(int i=0;i<D;i++){sum_for_sigma_d_y[i]=0.;}
for(int i=0;i<D;i++){
for(int j=0;j<D;j++){
if(j!=i && average[j]!=0.)
{sum_for_sigma_d_y[i]+=pow(d_y[i]*d_y[j]*Dy[j]*sigma_average[j]/average[j],2.);}
}
}
for(int i=0;i<D;i++){
if(average[i]=!0.){sigma_d_y[i]=pow(d_y[i]*(1-d_y[i]*Dy[i])*sigma_average[i]/average[i],2.);}
}
for(int i=0;i<D;i++){sigma_d_y[i]+=sum_for_sigma_d_y[i];}
//nuovo sigma d(y)
for(int i=0;i<D;i++){if(f_y[i]!=0.)
sigma_d_y[i]=d_y[i]*sqrt(pow(sigma_f_y[i]/f_y[i],2.)+pow(sigma_y_bar_F/y_bar_F,2.));}
//nuovo sigma y*d(y)
for(int i=0;i<D;i++){sigma_yd_y[i]=sigma_d_y[i]*y_comp[i];}
char outputfile_errori[400];
string outfile_errori=workdir+"/giunta_compat_errori.txt";
strcpy(outputfile_errori, outfile_errori.c_str());
ofstream OutputFile_errori;
OutputFile_errori.open(outputfile_errori);
for(int i=0;i<D;i++) {
OutputFile_errori << y_comp[i] << " " << sigma_average[i] << " " << sigma_f_y[i] <<
" " << sigma_d_y[i] << " " << sigma_yf_y[i] << " " << sigma_yd_y[i] << endl;
}
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OutputFile_errori.close();
return D;
}
A.5 Fermi Fit
void error_matrix(double A, double B, double C, int D, double x[], double y[], double
sigma_y[], double& sigma_A, double& sigma_B, double& sigma_C){
double dy_dA[D], dy_dB[D], dy_dC[D];
for(int i=0;i<D;i++){
dy_dA[i]=pow(1.+exp(B*x[i]-B*C),-1);
dy_dB[i]=-A*pow(dy_dA[i],2)*exp(B*x[i]-B*C)*(x[i]-C);
dy_dC[i]=-dy_dB[i]*B/(x[i]-C);
}
double a[3][3];
for(int i=0;i<3;i++){a[0][i]=0., a[1][i]=0., a[2][i]=0.;}
for(int i=0;i<D;i++){a[0][0]+=pow(dy_dA[i],2)/(sigma_y[i]*sigma_y[i]);}
for(int i=0;i<D;i++){a[1][1]+=pow(dy_dB[i],2)/(sigma_y[i]*sigma_y[i]);}
for(int i=0;i<D;i++){a[2][2]+=pow(dy_dC[i],2)/(sigma_y[i]*sigma_y[i]);}
for(int i=0;i<D;i++){a[0][1]+=dy_dA[i]*dy_dB[i]/(sigma_y[i]*sigma_y[i]);}
for(int i=0;i<D;i++){a[0][2]+=dy_dA[i]*dy_dC[i]/(sigma_y[i]*sigma_y[i]);}
for(int i=0;i<D;i++){a[1][2]+=dy_dB[i]*dy_dC[i]/(sigma_y[i]*sigma_y[i]);}
a[1][0]=a[0][1];
a[2][0]=a[0][2];
a[2][1]=a[1][2];
double det=a[0][0]*(a[1][1]*a[2][2]-a[2][1]*a[1][2])-a[0][1]*(a[1][0]*a[2][2]
-a[2][0]*a[1][2])+a[0][2]*(a[1][0]*a[2][1]-a[2][0]*a[1][1]);
double inv[3][3];
inv[0][0]=(a[1][1]*a[2][2]-a[1][2]*a[2][1])/det;
inv[0][1]=(a[0][2]*a[2][1]-a[0][1]*a[2][2])/det;
inv[0][2]=(a[0][1]*a[1][2]-a[0][2]*a[1][1])/det;
inv[1][0]=(a[1][2]*a[2][0]-a[1][0]*a[2][2])/det;
inv[1][1]=(a[0][0]*a[2][2]-a[0][2]*a[2][0])/det;
inv[1][2]=(a[0][2]*a[1][0]-a[0][0]*a[1][2])/det;
inv[2][0]=(a[1][0]*a[2][1]-a[1][1]*a[2][0])/det;
inv[2][1]=(a[0][1]*a[2][0]-a[2][1]*a[0][0])/det;
inv[2][2]=(a[0][0]*a[1][1]-a[0][1]*a[1][0])/det;
sigma_A=sqrt(inv[0][0]);
sigma_B=pow(inv[1][1],0.5);
sigma_C=pow(inv[2][2],0.5);
}
//------------------------------------------------------------------------------------------------------------------------------------
double fit(double& lambda, double& guess_A, double& guess_B, double& guess_C, int D,
double x[], double y[], double sigma_y[]){
double chisquare=0.;
double f_x[D];
for(int i=0;i<D;i++){f_x[i]=guess_A*pow(1.+exp(guess_B*x[i]-guess_B*guess_C),-1);}
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for(int i=0;i<D;i++){
chisquare+=pow(y[i]-f_x[i],2)/y[i];
}
qDebug() << "old chi-square: " << chisquare;
/************************************************************************************************/
double dy_dA[D], dy_dB[D], dy_dC[D];
for(int i=0;i<D;i++){
dy_dA[i]=pow(1.+exp(guess_B*x[i]-guess_B*guess_C),-1);
dy_dB[i]=-guess_A*pow(dy_dA[i],2)*exp(guess_B*x[i]-guess_B*guess_C)*(x[i]-guess_C);
dy_dC[i]=-dy_dB[i]*guess_B/(x[i]-guess_C);
}
double alpha[3][3];
for(int i=0;i<3;i++){alpha[0][i]=0., alpha[1][i]=0., alpha[2][i]=0.;}
for(int i=0;i<D;i++){alpha[0][0]+=pow(dy_dA[i],2)/(sigma_y[i]*sigma_y[i]);}
for(int i=0;i<D;i++){alpha[1][1]+=pow(dy_dB[i],2)/(sigma_y[i]*sigma_y[i]);}
for(int i=0;i<D;i++){alpha[2][2]+=pow(dy_dC[i],2)/(sigma_y[i]*sigma_y[i]);}
for(int i=0;i<D;i++){alpha[0][1]+=dy_dA[i]*dy_dB[i]/(sigma_y[i]*sigma_y[i]);}
for(int i=0;i<D;i++){alpha[0][2]+=dy_dA[i]*dy_dC[i]/(sigma_y[i]*sigma_y[i]);}
for(int i=0;i<D;i++){alpha[1][2]+=dy_dB[i]*dy_dC[i]/(sigma_y[i]*sigma_y[i]);}
alpha[1][0]=alpha[0][1];
alpha[2][0]=alpha[0][2];
alpha[2][1]=alpha[1][2];
double alpha_new[3][3];
for(int k=0;k<3;k++){
for(int l=0;l<3;l++){
if(k==l) alpha_new[k][l]=alpha[k][l]*(1.+lambda);
if(k!=l) alpha_new[k][l]=alpha[k][l];
}
}
double X[3][3]; //The inverse of alpha_new
double det; //The determinant of alpha_new
double a = alpha_new[0][0]*( alpha_new[1][1]*alpha_new[2][2] -
alpha_new[2][1]*alpha_new[1][2] );
double b = alpha_new[0][1]*( alpha_new[1][0]*alpha_new[2][2] -
alpha_new[2][0]*alpha_new[1][2] );
double c = alpha_new[0][2]*( alpha_new[1][0]*alpha_new[2][1] -
alpha_new[2][0]*alpha_new[1][1] );
det = a - b + c;
// Calculate the inverse matrix
X[0][0]=(alpha_new[1][1]*alpha_new[2][2]-alpha_new[1][2]*alpha_new[2][1])/det;
X[0][1]=(alpha_new[0][2]*alpha_new[2][1]-alpha_new[0][1]*alpha_new[2][2])/det;
X[0][2]=(alpha_new[0][1]*alpha_new[1][2]-alpha_new[0][2]*alpha_new[1][1])/det;
X[1][0]=(alpha_new[1][2]*alpha_new[2][0]-alpha_new[1][0]*alpha_new[2][2])/det;
X[1][1]=(alpha_new[0][0]*alpha_new[2][2]-alpha_new[0][2]*alpha_new[2][0])/det;
X[1][2]=(alpha_new[0][2]*alpha_new[1][0]-alpha_new[0][0]*alpha_new[1][2])/det;
X[2][0]=(alpha_new[1][0]*alpha_new[2][1]-alpha_new[1][1]*alpha_new[2][0])/det;
X[2][1]=(alpha_new[0][1]*alpha_new[2][0]-alpha_new[2][1]*alpha_new[0][0])/det;
X[2][2]=(alpha_new[0][0]*alpha_new[1][1]-alpha_new[0][1]*alpha_new[1][0])/det;
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//increments
double dA=0., dB=0., dC=0.;
double beta[3];
for(int k=0;k<3;k++){beta[k]=0.;}
for(int i=0;i<D;i++){beta[0]+=(y[i]-f_x[i])*dy_dA[i]/(sigma_y[i]*sigma_y[i]);}
for(int i=0;i<D;i++){beta[1]+=(y[i]-f_x[i])*dy_dB[i]/(sigma_y[i]*sigma_y[i]);}
for(int i=0;i<D;i++){beta[2]+=(y[i]-f_x[i])*dy_dC[i]/(sigma_y[i]*sigma_y[i]);}
for(int k=0;k<3;k++){dA+=beta[k]*X[0][k], dB+=beta[k]*X[1][k], dC+=beta[k]*X[2][k];}
double chisquare_new=0.;
double f_x_new[D];
for(int
i=0;i<D;i++){f_x_new[i]=(guess_A+dA)*pow(1.+exp((guess_B+dB)*x[i]-(guess_B+dB)*(guess_C+dC)),-1);}
for(int i=0;i<D;i++){
chisquare_new+=pow(y[i]-f_x_new[i],2)/y[i];
}
qDebug() << "new chi-square: " << chisquare_new;
qDebug() << "A= " << guess_A << " + " << dA;
qDebug() << "B= " << guess_B << " + " << dB;
qDebug() << "C= " << guess_C << " + " << dC << endl;
if(chisquare_new>=chisquare) {double temp=lambda; lambda=temp*10.;}//lambda=temp*1.1
if(chisquare_new<chisquare) {double temp=lambda; lambda=temp/10.;
guess_A+=dA,guess_B+=dB,guess_C+=dC;}//lambda=temp/1.1
double diff;
if(chisquare_new>=chisquare) diff=chisquare_new-chisquare;
if(chisquare_new<chisquare) diff=chisquare-chisquare_new;
return diff;
}
//------------------------------------------------------------------------------------------------------------------------------------
int exp_fit(std::string workdir, double start, double stop){
char inputfile[400];
string infile=workdir+"/giunta_compat.txt";
strcpy(inputfile, infile.c_str());
char inputfile_errors[400];
string infile_errors=workdir+"/giunta_compat_errori.txt";
strcpy(inputfile_errors, infile_errors.c_str());
char outputfile[400];
string outfile=workdir+"/fermi_fit.txt";
strcpy(outputfile, outfile.c_str());
ifstream In;
In.open(inputfile);
if (!In) {return 0;}
string s;
int DIM=0;
while(!In.eof()){getline(In,s,’\n’);DIM++;}
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In.close();
/************************************************************************************************/
ifstream InputFile;
InputFile.open(inputfile);
double y_comp[DIM-1], average[DIM-1], n_norm_comp[DIM-1], Dy[DIM-1], f_y[DIM-1],
d_y[DIM-1], yf_y[DIM-1], yd_y[DIM-1];
for(int i=0;i<DIM-1;i++){y_comp[0]=0., average[0]=0., n_norm_comp[0]=0., Dy[0]=0.,
f_y[0]=0., d_y[0]=0., yf_y[0]=0., yd_y[0]=0.;}
for(int i=0;i<DIM-1;i++){
InputFile >> y_comp[i] >> average[i] >> n_norm_comp[i] >> Dy[i] >> f_y[i] >> d_y[i]
>> yf_y[i] >> yd_y[i];
}
InputFile.close();
ifstream InputFile_errors;
InputFile_errors.open(inputfile_errors);
double sigma_average[DIM-1], sigma_f_y[DIM-1], sigma_d_y[DIM-1], sigma_yf_y[DIM-1],
sigma_yd_y[DIM-1];
for(int i=0;i<DIM-1;i++){sigma_average[0]=0., sigma_f_y[0]=0., sigma_d_y[0]=0.,
sigma_yf_y[0]=0., sigma_yd_y[0]=0.;}
for(int i=0;i<DIM-1;i++){
InputFile_errors >> y_comp[i] >> sigma_average[i] >> sigma_f_y[i] >> sigma_d_y[i] >>
sigma_yf_y[i] >> sigma_yd_y[i];
}
InputFile_errors.close();
/************************************************************************************************/
int N=0, min=0, max=0;
for(int i=0;i<DIM-1;i++){
if(start>=y_comp[i] && start<y_comp[i+1]) min=i;
if(stop>=y_comp[i] && stop<y_comp[i+1]) max=i;
}
N=max-min;
double mV_data[N+1], yd_y_data[N+1], sigma_yd_y_data[N+1];
for(int i=0;i<N+1;i++){mV_data[i]=0., yd_y_data[i]=0., sigma_yd_y_data[i]=0.;}
for(int i=0;i<N+1;i++){
mV_data[i]=(y_comp[min+i]);
yd_y_data[i]=yd_y[min+i];
sigma_yd_y_data[i]=yd_y_data[min+i];
}
double max_value=yd_y_data[0], max_key=mV_data[0];
for(int i=0;i<N+1;i++){if(yd_y_data[i]>max_value) {max_value=yd_y_data[i],
max_key=mV_data[i];}}
double min_value=yd_y_data[0], min_key=mV_data[0];
for(int i=0;i<N+1;i++){if(yd_y_data[i]<min_value) {min_value=yd_y_data[i],
min_key=mV_data[i];}}
double guess_A=max_value-min_value;
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double guess_C=0.5*(min_key+max_key)*(2./3.);
double sum_guess_B=0.; int counts=0;
for(int i=0;i<N+1;i++){
if(guess_A/yd_y_data[i]-1.>0){sum_guess_B+=log(guess_A/yd_y_data[i]-1.)/(mV_data[i]-guess_C);
counts++;}
}
double guess_B=sum_guess_B/(1.*counts);
qDebug() << "Initial set: " << guess_A << " " << guess_B << " " << guess_C;
/************************************************************************************************/
double lambda=0.001;//lambda=0.1
double diff=fit(lambda,guess_A,guess_B,guess_C, N+1, mV_data, yd_y_data,
sigma_yd_y_data);
int counter=0;
while(diff>=0.003){
diff=fit(lambda,guess_A,guess_B,guess_C, N+1, mV_data, yd_y_data,
sigma_yd_y_data); counter++;
qDebug() << " --- iteration no.: " << counter;
qDebug() << "A: " << guess_A << ", B: " << guess_B << ", C: " << guess_C << ",
lambda: " << lambda;
}
qDebug() << "Final set: " << guess_A << " " << guess_B << " " << guess_C << " ---
iteration no.: " << counter;
double A=guess_A, B=guess_B, C=guess_C;
double sigma_A=0., sigma_B=0., sigma_C=0.;
error_matrix(A, B, C, N+1, mV_data, yd_y_data, sigma_yd_y_data, sigma_A, sigma_B,
sigma_C);
/************************************************************************************************/
ofstream OutputFile;
OutputFile.open(outputfile);
OutputFile << A << " " << B << " " << C << endl;
OutputFile << sigma_A << " " << sigma_B << " " << sigma_C << endl;
for(int i=0;i<N+1;i++){
OutputFile << mV_data[i] << " " << yd_y_data[i] << " " <<
A/(1.+exp(B*(mV_data[i]-C))) << endl;
}
OutputFile.close();
return DIM;
}
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